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Abstract
How will hosts and pathogens coevolve in response to multiple types of hosts? I study this
question from three different perspectives. First, I model a scenario in which hosts are catego-
rized as female or male. Hosts invest resources in maintaining their immune system at a cost to
their reproductive success, while pathogens face a trade-off between transmission and duration
of infection. Importantly, female hosts are also able to vertically transmit an infection to their
newborn offspring. The main result is that as the rate of vertical transmission increases, fe-
male hosts will have a greater incentive to pay the cost to invest in their immune system, while
the pathogen will evolve a lower rate of disease-induced mortality in female hosts relative to
male hosts. Second, I study a model where hosts can change their type. Hosts are classified
according to whether they engage or do not engage in prophylactic behaviours that reduce the
transmission rate of an infectious disease and may freely start or stop these behaviours. I study
the evolution of the degree to which the pathogen exploits its host’s resources. The main re-
sult is that, when hosts engage in prophylaxis, I expect pathogens to evolve a lower level of
host exploitation than would otherwise be predicted in the absence of prophylactic behaviours.
Finally, I consider the possibility of multiple pathogen strains in addition to multiple types of
hosts. I develop a general theoretical framework to link ideas from evolutionary epidemiol-
ogy to those from kin selection theory to study the evolution of coinfecting pathogen strains.
The main result is that pathogens will evolve to balance both the direct and indirect benefits
of increased transmission with the associated direct and indirect costs of decreased duration
of infection within each type of host. The more genetically related is a pathogen strain to
its coinfecting group, the more it will reduce its own disease-induced mortality rate for the
benefit of the whole group. Overall, this work shows how standard results from evolutionary
epidemiology change when considering the coevolution of hosts and pathogens in the presence
of multiple types of hosts.
Keywords: disease dynamics, epidemiology, evolution, game theory, inclusive fitness, kin
selection, mathematical model, natural selection, Price equation, sexual selection
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Summary for Lay Audience
Pathogens and their hosts evolve over time. Researchers build mathematical models to
study this evolution and make predictions about the long-term behaviour of host-pathogen sys-
tems. A great deal of work has been done to understand the forces that shape the evolution
of pathogens and the degree to which they harm their hosts. Other researchers have studied
how hosts and pathogens evolve together, as changes in one group will affect the other group.
They have shown that considering the evolution of both groups simultaneously allows us to
make new and different predictions than if we consider only the evolution of one group. An
area of interest which has received less attention is how hosts and pathogens evolve together
when the host population is subdivided into different types. Host populations often have defin-
ing characteristics, such as sex or age, that can be used to distinguish subgroups within that
population. Empirical evidence has shown that pathogens faced with these different types of
hosts can evolve to behave differently in one type of host than in the other, and that this will, in
turn, affect the evolution of the hosts themselves. This thesis addresses this area of research by
building mathematical models and drawing predictions on how we expect hosts and pathogens
to evolve when hosts are grouped into different types. I show that the evolution of hosts and
pathogens together and the existence of different types of hosts are important features that can
generate new evolutionary predictions, which can be used to help explain some of the trends
observed in real host-pathogen systems.
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1.1 Mathematical Models of Infectious Diseases
Some of the earliest models of epidemics are those of Ross [1] and Kermack and McKendrick
[2]. Both used systems of differential equations to describe the progression of an infectious
disease through a population of individuals. One of their main goals was to estimate the num-
ber of individuals who would contract the disease by the end of the epidemic. An important
quantity in the study of such models is the basic reproductive number of the pathogen, which is
defined as the expected number of new infections created by a single infected individual over
the duration of an infection, in an entirely susceptible population [3]. This quantity can be used
to predict if a disease will spread within a population (R0 > 1) or die out (R0 < 1) [4].
Later models expanded on this to consider diseases which are persistent in a population. A
simple model of such endemic diseases compartmentalizes a population of N individuals into
those who are infected with the disease and those who are not infected but are susceptible to
infection [4]. At any time t, there will be S = S (t) individuals susceptible to infection and
I = I(t) individuals infected with the disease. All infected individuals are also infective. New
individuals will be born at a per-capita rate b and all newborns are assumed to be susceptible
to infection. Susceptible and infected individuals will die at a per-capita rate µ due to causes
1
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unrelated to the disease.
Transmission of the disease will occur at a per-capita rate βS when an infected individual
comes into contact with a susceptible individual. Infected individuals may clear their infection
at a per-capita rate γ and become susceptible to reinfection. Infected individuals will also
experience an additional per-capita disease-induced mortality rate α.




= bN + γI − βS I − µS (1.1a)
dI
dt
= βS I − (γ + µ + α)I, (1.1b)
where N = S + I. Numerical iteration can be used to approximate solutions to system (1.1)
and estimate the numbers of susceptible and infected individuals at any given time. Figure 1.1
shows numerical solutions to (1.1) for a given set of parameter values. After a short period of
oscillation, the numbers of susceptible and infected individuals settle to a steady state. This
steady state, or equilibrium, is important from a biological perspective because it tells us how
much of the population we expect to eventually be infected with the disease [4].
In more complicated models, we will only be able to approximate the equilibria. How-
ever, model (1.1) is simple enough that we can derive analytical expressions for all possible
equilibria. An equilibrium of (1.1) is defined as a point at which the numbers of susceptible
and infected individuals are not changing; individuals will still move between compartments,
but as one individual leaves a given compartment it is immediately replaced by another in-
dividual [4]. Mathematically, this is equivalent to simultaneously solving dS/dt = 0 and
dI/dt = 0. Assuming b , µ, solving these equations yields two possible equilibrium states
of (1.1): a disease-free equilibrium (DFE), where there are no individuals infected with the
disease, given by (S̄ DFE, ĪDFE) = (0, 0); and an endemic equilibrium (EE), where there are some
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Figure 1.1: Example solutions to system (1.1). After a transient period, the numbers of suscep-
tible and infected individuals settle at a steady state. Model parameters: b = 4, γ = 5, β = 4,
µ = 2.
the case where b = µ, the DFE no longer coincides with the trivial or extinction equilibrium
(S̄ DFE, ĪDFE) = (0, 0). Instead, there is an infinite number of disease-free equilibria of the form
(S̄ DFE, ĪDFE) = (S̄ , 0), for any non-negative real number S̄ . However, none of these equilibria
are stable since any small perturbation in S̄ will result in a new equilibrium point. Throughout
the remainder of this thesis, it is assumed that parameters are chosen so that there is a unique
DFE which coincides with the trivial or extinction equilibrium (S̄ DFE, ĪDFE) = (0, 0), as well as








Of these two possible equilibria, which one will system (1.1) actually move towards? To
answer this, we study the stability of both the DFE and the EE. The stability of a particular
equilibrium is determined by first constructing the Jacobian matrix, the matrix of first partial
derivatives, of (1.1) and evaluating it at the equilibrium. If the eigenvalues of the resulting
matrix are all negative or have negative real parts, then we conclude that the equilibrium is
stable and that solutions of (1.1) will converge towards it over time; otherwise, the equilibrium
4 Chapter 1. Introduction













b − µ − βI b + γ − βSβI βS − γ − µ − α
 . (1.2)
First, we will determine the stability of the DFE. Evaluating (1.2) at the DFE gives
JDFE =
b − µ b + γ0 −γ − µ − α
 . (1.3)
Since (1.3) is an upper triangular matrix, the eigenvalues are the entries on the main diagonal.
In particular, the eigenvalues are λ1 = b − µ and λ2 = −γ − µ − α. Since all of the model
parameters are assumed to be positive, we have that λ2 < 0. The stability of the DFE then rests
on the sign of λ1. If λ1 < 0, i.e., b < µ, then both eigenvalues are negative and the DFE is
stable. If λ1 > 0, i.e., b > µ, then the DFE is unstable.











(γ + µ + α) 0
 . (1.4)
We could proceed as before and find the eigenvalues of (1.4), but the expressions for the eigen-
values will be more mathematically complicated than in the case of the DFE. Alternatively,
we can use the Routh-Hurwitz criteria to determine the stability of the EE. The Routh-Hurwitz
criteria for a 2 × 2 matrix A state that all eigenvalues of A are negative or have negative real
parts if and only if tr(A) < 0 and det(A) > 0 [4]. In this case, the trace and determinant of (1.4)
will be easier to compute and analyze than the eigenvalues. First, the determinant of (1.4) is
given by det(JEE) = (b − µ)(γ + µ + α). This quantity is positive whenever b > µ, which is also
what must be true in order for the DFE to be unstable. Second, the trace of (1.4) is given by





. Since we already know we must have b > µ, this quantity will
be negative whenever γ+µ+α
µ+α−b > 1. Due to the fact that all model parameters are positive, we
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must have that
∣∣∣∣γ+µ+αµ+α−b ∣∣∣∣ > 1 so it only remains to establish that γ+µ+αµ+α−b > 0. This is true as long as
b < µ+α. So, in summary, the EE is stable whenever µ < b < µ+α, and is unstable otherwise.
1.2 Evolution of Pathogens
One limitation of the above model is that it assumes that pathogen traits (e.g., disease-induced
mortality) are fixed. Realistically, pathogens evolve over time. How do we mathematically
study this evolution and make predictions about where natural selection will push pathogen
traits?
The theory of adaptive dynamics [5, 6, 7] was developed to answer questions like this.
Carrying on with the example model developed in the previous section, we start by supposing
that we have some resident population governed by (1.1) and that this resident system has
settled at its EE. We then assume that a rare mutant strain of the pathogen, with a disease-
induced mortality rate α̃ and a transmission rate β̃, is introduced into the equilibrium resident
population. If we use Ĩ = Ĩ(t) to denote the number of hosts infected with the mutant strain,
then we can model its dynamics with
dĨ
dt
= β̃S̄ Ĩ − (γ + µ + α̃)Ĩ, (1.5)
where S̄ represents the number of susceptible hosts at the resident EE. Will this mutant pathogen
strain die out, or will it grow and establish itself in the population?
To answer this, we first need to establish the effects that will cause the pathogen to change
its disease-induced mortality rate. In particular, we must define the benefit gained and the
cost incurred for increased disease-induced mortality. One of the most common approaches is
to assume that the pathogen faces a trade-off between the rate at which it can transmit itself
between hosts and its duration of infection within a host [8]. Biologically, a pathogen will
exploit its host’s resources in order to reproduce. Greater exploitation will result in an increased
number of replicates, making it more likely that the pathogen will transmit itself to another host
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but also making it more likely that the host is killed by the infection [9]. Such a trade-off was
shown by Anderson and May [10] in relation to HIV data, and by Ewald [11] in relation to
vector-transmitted diseases. Mathematically, this means that we treat the transmission rate
β (resp. β̃) as a function of the disease-induced mortality rate α (resp. α̃) of the pathogen
and write β = β(α). As discussed by Alizon and Michalakis [12], data suggests that this
relationship between transmission and disease-induced mortality should be represented by a
saturating function. Increased disease-induced mortality will then confer a benefit of increased
transmission rate, but will come at the cost of a shorter duration of infection 1
γ+µ+α
. Other
authors have assumed trade-offs between the pathogen and the host clearance rate γ, mediated
by disease-induced mortality [10, 11, 13], viral load [14], the degree to which a pathogen
exploits its host’s resources [15], or the pathogen growth rate [16].
We next need to define a measure of the fitness W = W(α̃, α) of the mutant pathogen strain
in order to determine how well the mutant strain performs against the established resident
strain. Two common measures of fitness are the instantaneous growth rate [7, 17] and the basic
reproductive number [12] of the mutant pathogen strain. The instantaneous growth rate can be
found from equation (1.5) to be β̃S̄ −γ−µ−α̃, and when this quantity is positive (resp. negative)
the mutant pathogen population is growing (resp. shrinking). The basic reproductive number,
denoted R0, is defined as the expected number of new infections created by a single infected








mutant pathogen population will grow (resp. shrink) if R̃0 > 1 (resp. R̃0 < 1).
Either of these quantities can be used as a measure of fitness and will yield the same evo-
lutionary results [18]. For our example model here, we will define fitness as the basic repro-
ductive number and write W(α̃, α) = β̃S̄
γ+µ+α̃
, where β̃ depends on the mutant disease-induced
mortality rate α̃ and S̄ depends on the resident disease-induced mortality rate α. We then look
1.2. Evolution of Pathogens 7











γ + µ + α∗
, (1.7)
where the prime denotes the first derivative. The left-hand side of (1.7) describes the relative
change in transmission for a change in disease-induced mortality, while the right-hand side
represents the average duration of infection. Equation (1.7), then, captures the trade-off faced
by the pathogen: increased disease-induced mortality will increase transmission but decrease
the duration of infection, and these two effects must balance out at evolutionary equilibrium.
This balance is a common theme, both in theoretical studies [8] and empirical studies [12].
Úbeda and Jansen showed that a similar balance exists in a model of hosts split into female
and male groups, while Alizon [16] showed that an analogous balance must be maintained in
the presence of transmission-recovery trade-offs, as well. If we assume a saturating functional
form for transmission and model it as β(α) = α1/2 (so that β̃ = β(α̃) = α̃1/2), as used by Day
and Burns [19], then we can use (1.7) to derive an explicit expression for the evolutionary
equilibrium: α∗ = γ + µ.
Similar to our treatment of the epidemiological equilibria in the previous section, we can
ask questions about the stability of this evolutionary equilibrium. Under what conditions do
we expect the pathogen population to converge to this evolutionary equilibrium? Since fitness
depends on both the mutant and resident traits, we need to concern ourselves with the stability
of the evolutionary equilibrium from two directions: the mutant direction and the resident
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and we say it is evolutionarily stable (sensu [20]). If the evolutionary equilibrium attracts











and we say it is convergence stable [21]. Strict versions of the inequalities (1.8) and (1.9)
provide sufficient conditions for stability. Both of these stability conditions are important for
establishing an endpoint of natural selection. An equilibrium can be evolutionarily stable but
not convergence stable, in which case nearby mutant strategies cannot invade the population but
nearby resident populations employing a different strategy will not necessarily have a lower fit-
ness than the focal population. Alternatively, an equilibrium can be convergence stable but not
evolutionarily stable, in which case nearby resident populations have a lower fitness than the
focal population but a nearby mutant strategy could invade and replace the equilibrium strat-
egy. We call an evolutionary equilibrium which is both evolutionarily stable and convergence
stable a continuously stable strategy (CSS) [22].























Since both (1.10) and (1.11) are negative, the evolutionary equilibrium α∗ = γ + µ is a CSS
and we expect that natural selection will, over time, push the pathogen population towards this
level of disease-induced mortality.
It is worth noting that in finding the evolutionary equilibrium α∗ and confirming that it is
a CSS, we have maximized the basic reproductive number [3] of the pathogen. Other authors
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have shown that natural selection acts to maximize R0 [10, 12, 19], but this literature often
focuses on the evolution of pathogen virulence. Virulence is defined to be the reduction in host
fitness due to infection with the disease [23]. Host fitness is comprised of two components:
survival and reproduction. In our example model, the pathogen is only able to influence host
survival, through its rate of disease-induced mortality, but has no effect on host reproduction.
In this case, it would be appropriate to refer to disease-induced mortality as pathogen virulence.
However, in more complicated models where the pathogen is potentially able to also influence
host reproduction (e.g., via vertical transmission, as in [15]), virulence will be more than just
the pathogen’s rate of disease-induced mortality.
1.3 Evolution of Hosts
We could also ask about modelling the evolution of changing host traits in (1.1). Doing so
involves a similar adaptive-dynamics approach [5, 6, 7] as with pathogen evolution. In our
example model, we will consider the clearance rate γ to be the host trait that is evolving.
First, we must determine the effects that will influence the evolution of host recovery. As
in the case of pathogen evolution, hosts will also face a trade-off. One of the most common
approaches is to model a trade-off between host clearance and reproduction. Biologically, a
host has only a finite amount of resources and choosing to invest in immune function necessar-
ily takes resources away from other life history traits, such as reproduction [24]. This idea has
been extended to models of hosts categorized into female and male groups to show that differ-
ent sexes are expected to evolve different levels of immune investment [25, 26, 27]. There is
also a distinction made in the literature between modelling host immune maintenance versus
activation. Immune maintenance considers the costs of diverting resources from reproduction
to immune function in order to maintain an immune system at all times [28]; in this framework,
all individuals incur the cost of investing in their immune system, regardless of disease status.
Alternatively, immune activation refers to the act of diverting resources from reproduction to
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immune function in order to combat an active infection [19, 29]; here, the cost of investing in
the immune system is paid only by infected individuals. We will focus here on immune system
maintenance. As in [28], we suppose that there is a maximal birth rate bmax which is reduced
at a cost c for investing resources in immune function, with the level of investment measured
by γ. This allows us to write b = b(γ) and model the birth rate as b(γ) = bmax − cγ [28].
Next, suppose that there is a resident host population governed by (1.1) and that this resident
system has reached the EE previously derived. We then imagine introducing a mutant host
whose clearance rate is given by γ̂. These mutant hosts will create new mutant host offspring
at a per-capita rate b̂ = b(γ̂). If we denote the number of susceptible mutant hosts by Ŝ = Ŝ (t)
and the number of infected mutant hosts by Î = Î(t), then we can approximate the dynamics of












βĪ + µ −γ̂
−βĪ γ̂ + µ + α





where overbars denote the EE levels of resident hosts. The matrix F describes the per-capita
rate of production of new mutant hosts, while the matrix −V describes transitions of individuals
between disease compartments and the loss of individuals from the population.
As in the case of pathogen evolution, we can define the fitness W = W(γ̂, γ) of the mutant
host in different ways. One way is to use the instantaneous growth rate of the mutant host
population, which is now defined as the largest eigenvalue, in the sense that it is the eigenvalue
which serves as an upper bound on the real parts of all of the other eigenvalues, of the matrix
F − V [17]. When this eigenvalue is positive (resp. negative), the mutant host population will
grow (resp. shrink). Alternatively, we can derive fitness from the next-generation matrix FV−1
[30, 31, 32]. The entries of this matrix describe the expected number of susceptible and infected
mutant hosts that will be created by a single susceptible or infected mutant host, and we can
use its dominant eigenvalue as a measure of fitness [30]. As discussed previously, regardless
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of how we measure fitness, we will arrive at the same evolutionary equilibrium [18].
In our example model, if we choose to measure fitness as the dominant eigenvalue of the
next-generation matrix [30], we get the following expression:
W(γ̂, γ) =
b̂(βĪ + γ̂ + µ + α)
µ(βĪ + γ̂ + µ + α) + αβĪ
. (1.13)






Stability conditions can also be derived for this equilibrium, as we did with the evolutionary
equilibrium of the pathogen. We say that the host evolutionary equilibrium γ∗ is evolutionarily

















As before, strict versions of these inequalities provide sufficient conditions for stability. An
evolutionary equilibrium which satisfies both (1.15) and (1.16) is called a continuously stable
strategy (CSS) [22].
Using the relationship between birth rate and clearance rate defined above, we can solve
(1.14) to find the evolutionary equilibrium clearance rate
γ∗ =
bmax − (µ + α) +
√
α[(1 − c)(µ + α) − bmax]
c
, (1.17)
where bmax and c are chosen so that γ∗ is both real and positive. We can also find the equilibrium
birth rate b∗ associated with γ∗: b∗ = µ + α −
√
α[(1 − c)(µ + α) − bmax]. To check the stability
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of γ∗, we evaluate conditions (1.15) and (1.16). Condition (1.15) is satisfied if and only if
b∗ > µ, which must be true since we are working under the assumption that the EE of (1.1)
is stable. Condition (1.16) is satisfied if and only if (µ + α − b∗)b∗ + αb∗ > 0, which must be
true because b∗ < µ + α is a necessary condition for the EE of (1.1) to be stable. Thus, the
evolutionary equilibrium clearance rate (1.17) is a CSS. Over time, we expect natural selection
to push the host population towards this clearance rate.
1.4 Host-Pathogen Coevolution
What if both host and pathogen traits are evolving? In our example model, the CSS levels
of disease-induced mortality and clearance depend on each other, so that changes in one will
cause changes in the other. To study the coevolution of hosts and pathogens, we look for a CSS
pair (α∗, γ∗) which simultaneously satisfies conditions (1.6), (1.8), and (1.9) for the pathogen
and conditions (1.14), (1.15), and (1.16) for the host. To find this pair, we would equate the
expressions found above for α∗ and γ∗.
While the adaptive-dynamics approach [5, 6, 7] discussed previously still applies, the trade-
offs faced by hosts and pathogens can become more complicated when the two groups are co-
evolving with one another. For example, if pathogens face at trade-off between transmission
and clearance [15, 16], then hosts balancing their resource investments between reproduction
and immune function can influence pathogen evolution through changing clearance rates. The
outcome of such an interaction was explored by van Baalen [28] in the case of host immune
maintenance. Coevolution, in this case, could lead to two possible stable evolutionary out-
comes: a state in which hosts invest little in their immune systems and pathogens are relatively
avirulent, and a state in which hosts invest heavily in their immune systems and pathogens ex-
press a higher level of virulence [28]. Conversely, the same outcome was not found by Day and
Burns [19] when considering host immune activation instead of maintenance. Day and Burns
[19] also highlight the importance of how virulence is measured. If virulence is measured not
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as disease-induced mortality but as case mortality, the probability of a host dying due to the
disease, then virulence is not affected by coevolutionary dynamics [19].
Coevolution can also be studied in cases where hosts and pathogens evolve on different time
scales. For example, Pharaon and Bauch [33] studied a model in which pathogen evolution re-
sponds to changes in host behaviour. Hosts choose whether or not to engage in prophylactic
behaviour, such as wearing a mask or social distancing. To model the proportion of individuals
engaging in prophylaxis, Pharaon and Bauch [33] use the replicator dynamic [34, 35], a differ-
ential equation which describes how the frequency of individuals adopting a given strategy (in
this case, engaging in prophylaxis) changes due to natural selection. In particular, if x = x(t)




∝ x(1 − x)(Wx − W̄), (1.18)
where Wx represents the fitness of a susceptible individual engaging in prophylaxis and W̄ rep-
resents the average fitness of a susceptible individual in the population [34, 35]. This provides
an alternative way of studying evolution than adaptive dynamics [5, 6, 7]. Host behaviour
then evolves on a much faster time scale than pathogen disease-induced mortality, and the
model effectively assumes that hosts reach a quasi-equilibrium before analyzing the evolution
of pathogens [33]. This methodology is in contrast to that described above of using an adaptive-
dynamics approach [5, 6, 7] to study the evolution of both host and pathogen populations.
1.5 Multiple Pathogen Strains
One way in which the previous models on evolution can be extended is by considering the
effects of multiple strains of the pathogen. Coinfection by multiple strains is a feature of many
infectious diseases, such as influenza [36], malaria [37], and dengue [38].
One approach to studying coinfection is to pair an epidemiological model, such as (1.1),
with a model of the within-host dynamics of the pathogen strains [39]. Authors following
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this approach have taken into account such things as pathogen exploitation of host resources
[40], the production of molecules used as a public good by the group of coinfecting pathogens
[41], and the interaction between pathogens and host lymphocytes [42]. Much of this literature
assumes that different pathogen strains compete for resources within the host, and show that
the exact nature of the interactions between strains will determine the evolutionary outcome.
An alternative approach is to use tools from kin selection theory. Instead of explicitly
modelling interactions between pathogen strains within hosts, this approach summarizes those
within-host dynamics by using the coefficient of relatedness between a focal pathogen strain
and its coinfecting group [43, 44]. In doing so, some biological details are sacrificed but the
resulting model yields evolutionary predictions less beholden to specific assumptions about
population dynamics. The guiding principle of this approach is to consider the fitness of a
focal pathogen strain as a function of the genotype of that focal strain [43, 44]. Doing so
shows that, at evolutionary equilibrium, a focal pathogen strain must balance the benefit to
itself of increased transmission against both the direct cost to itself of increased clearance and
the indirect cost to its coinfecting group of decreased duration of infection [43]. One of the
main predictions from this literature is that increased relatedness among coinfecting pathogen
strains will select for reduced virulence [43, 44]. Effectively, the coinfecting pathogen strains
will behave more cooperatively the more related they are to one another, in keeping with the
ideas put forth by Hamilton [45].
One open question in this field of work is: How do these predictions change when multiple
pathogen strains coevolve with hosts, and how do evolution and coevolution proceed when sus-
ceptible and infected hosts can be further subdivided into additional categories? As discussed
previously, host-pathogen coevolution can produce new results and predictions than when con-
sidering pathogen evolution alone. It seems reasonable, then, to hypothesize that allowing hosts
to coevolve with multiple coinfecting pathogen strains could generate predictions not seen in
the above literature on multiple pathogen strains.
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1.6 Multiple Types of Hosts
Another way in which we can build on the models discussed previously is to consider the
effects of multiple types of hosts. Mathematically, in models with multiple types of hosts, the
pathogen will exhibit a different level of virulence and have a different fitness in each type
of host [17]. To make evolutionary predictions, we then look to track the direction in which
natural selection pushes pathogen virulence within each type of host [17].
As an example, many pathogens affect female and male hosts differently, such as those
that cause bacterial meningitis [46] or tuberculosis [47]. In modelling these scenarios, the host
population is split into susceptible and infected females, and susceptible and infected males.
The pathogen expresses a certain disease-induced mortality rate in female hosts and a poten-
tially different disease-induced mortality rate in males, and we look for CSS values of both of
these traits using the adaptive-dynamics techniques discussed previously [17]. The sexes are
typically differentiated based on their level of immune system investment, and models predict
that the pathogen will evolve a higher level of disease-induced mortality in the sex that invests
more heavily in its immune system [48]. Other work has shown that, in the presence of vertical
transmission from female hosts to newborn offspring, pathogens are expected to evolve a lower
level of disease-induced mortality in females due to this additional transmission pathway [15].
Alternatively, we can look at host evolution, where previous authors have shown that sexual
selection can shape sex differences in host immune defense [24, 25, 27] and susceptibility to
infection [26], or differing transmission and disease-induced mortality rates between the sexes
[29]. Notably, all of this work focuses either on pathogen evolution or on host evolution, but
not on the coevolution of both groups. Given that coevolution has been shown to produce
qualitatively different results than considering only the evolution of one group, it is reasonable
to ask how these results on sex-specific differences change when hosts and pathogens evolve
together.
Another example involves classifying hosts according to whether or not they engage in
some prophylactic measure, such as hand washing or social distancing, to protect against an
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infectious disease. Much research has been conducted on hosts choosing to vaccinate against a
disease [49]. In the case of human papillomavirus, for example, theory has predicted that vac-
cination can select for higher levels of pathogen virulence [50]. Other work has shown that the
direction in which natural selection pushes a pathogen population depends on the mechanism
by which the vaccine works [51, 52]. In contrast, we can also model impermanent types of be-
haviour, such as social distancing or wearing a mask, which hosts may choose to start or stop
at any time. Work in this area has derived conditions under which a more virulent pathogen
strain can or cannot successfully invade a resident population containing a less virulent strain
[33]. However, this latter work considers only short-term pathogen competition, and does not
make predictions about evolutionary stability or where natural selection will push a pathogen
population over longer periods of time.
1.7 Contributions of this Thesis
Throughout this chapter, I have explored some of the key literature on evolutionary epidemi-
ology and highlighted some questions that remain unanswered. I propose that coevolution
and multiple types of hosts are important factors governing real host-pathogen systems, and
that accounting for these factors in mathematical models can generate qualitatively different
predictions than previous literature which neglects either of these effects. In the remaining
chapters of this thesis, I provide three examples of original research supporting this claim.
Each example will begin with a review of relevant literature in addition to the literature already
discussed in this chapter. Matlab code used in Chapters 2 and 3 is available on the GitHub
repository located at https://github.com/evanjmitchell/doctoral-thesis.
In Chapter 2, I study a population of hosts split into females and males, and investigate
how coevolution of hosts and pathogens responds to the presence of multiple types of hosts.
Female hosts show a stronger immune response than male hosts across many infectious dis-
eases, while male hosts tend to experience a higher disease-induced mortality rate than female
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hosts. Previous evolutionary explanations of this phenomenon have focused exclusively on
either host or pathogen evolution. Here, I build a coevolutionary model where both host and
pathogen populations evolve in response to changes in either population. I also include the
effects of vertical transmission, a crucial selective pressure felt only by female hosts and which
has been neglected in previous theories. For high rates of vertical transmission, I predict that
female hosts will evolve a higher level of immune system investment than male hosts while
pathogens will evolve a higher rate of disease-induced mortality in males relative to females.
By including the effects of vertical transmission and establishing this result in a coevolutionary
setting, I provide a more complete explanation of the trend observed across a wide variety of
infectious diseases.
In Chapter 3, I study a scenario in which hosts are able to change from one type to another.
I build a model of sublethal disease effects where hosts are able to choose to engage in pro-
phylactic measures that reduce the likelihood of disease transmission. This choice is mediated
by utility costs and benefits associated with prophylaxis, and the fraction of hosts engaged in
prophylaxis is also affected by population dynamics. As in [33], I model host behaviour using
the replicator dynamic [34] and assume that it evolves to a quasi-equilibrium before studying
the long-term evolution of pathogens. When prophylactic host behaviour occurs, I find that the
level of pathogen host exploitation is reduced, by the action of selection, relative to the level
that would otherwise be predicted in the absence of prophylaxis. This work emphasizes the
significance of the transmission-recovery trade-off faced by the pathogen and the ability of the
pathogen to influence host prophylactic behaviour.
In Chapter 4, I consider the possibility of multiple pathogen strains in addition to multiple
types of hosts. I develop a general theoretical framework to link ideas from evolutionary epi-
demiology to those from kin selection theory to study the evolution of coinfecting pathogen
strains. The main result is that pathogens will evolve to balance both the direct and indirect
benefits of increased transmission with the associated direct and indirect costs of decreased
duration of infection within each type of host. Importantly, the trait value which achieves this
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balance can differ between host types and is affected by coevolutionary dynamics. Further-
more, the more genetically related is a pathogen strain to its coinfecting group, the more it will
reduce its own disease-induced mortality rate for the benefit of the whole group.
Finally, in Chapter 5, I provide some summarizing remarks and discuss possible directions
for future research work.
Chapter 2
Female Reproduction and the Evolution of
Sex-specific Differences in Immunity
2.1 Introduction
Many clinical studies on infectious diseases show a trend of female hosts maintaining a stronger
immune system and experiencing a lower level of disease-induced mortality than male hosts
[53]. This trend is seen across a wide variety of infectious diseases, such as bacterial meningitis
[46], tuberculosis [47], and infections caused by Staphylococcus aureus [54]. These observa-
tions have been attributed to inherent genetic differences between the sexes [55, 56, 57, 58],
but a full evolutionary explanation is not readily available. What selective pressures could
have pushed females to invest more heavily in their immune system? How did evolution lead
to pathogens that inflict a lower level of disease-induced mortality in females than in males?
Two theories currently exist to address the first of these questions. One theory argues
that differences in immunity between the sexes are the result of females choosing males with
attractive features as reproductive partners [24, 25, 26]. While male sex hormones may enhance
their attractiveness, they also act as immune suppressants [24, 25, 26]. Thus, sexual selection
for attractive males should result in a weaker immune response in males relative to females
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[24, 25, 26, 27]. In this case, reduced immune response is simply the cost of being attractive
and this cost is unique to males.
A second theory in shaping patterns of host immunity emphasizes the role of pathogen life-
history traits. Different infection rates or disease-induced mortality rates in female versus male
hosts can select for sex-specific levels of immune investment. In particular, if males experience
a higher infection rate than females, or if females experience a higher disease-induced mortality
rate, then natural selection leads to a greater immune response in females relative to males [29].
In this case, it is the pathogen, not the mating system, that leads selection to shape the host’s
response to infection in a sex-specific manner.
Both of these explanations neglect host-pathogen coevolution. They take, as given, that a
pathogen exhibits a higher level of disease-induced mortality in one sex relative to the other
and predict where this will lead host evolution. The subsequent evolutionary response from the
pathogen is ignored.
In order to develop a more complete explanation of the pattern observed in clinical studies
of increased immunity and decreased disease-induced mortality in females, we investigate the
coevolution of both hosts and pathogens as a result of natural and sexual selection. Further-
more, we also include the possibility of a female infecting her newborn offspring via vertical
transmission. Vertical transmission is observed in many infectious diseases, such as dengue
[59], human papillomavirus [60], and hepatitis B [61], and is experienced exclusively by fe-
males. The possibility of vertical transmission means that a female investing more heavily in
her immune system will reduce the likelihood of infecting her newborn offspring, conferring
to her a fitness benefit. This benefit trades off against a cost to reproductive success. Vertical
transmission adds an extra dimension to the evolutionary pressures felt by females, as there
is now a reproductive benefit for females to invest in their immune system where before there
was only a cost. This extra dimension is crucial to fully understand how selection shapes fe-
male immune investment and has been neglected in previous theories of the evolution of host
immune response.
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Here, we develop a model where female and male hosts can evolve different levels of
immune-system investment (measured by their sex-specific rates of recovery) and pathogens
can evolve sex-specific levels of disease-induced mortality. Asymmetry between the sexes is
introduced via differences in the reproductive cost to immune investment and via the inclusion
of vertical transmission. Our model predicts that sex differences in the reproductive cost to
immune investment select for a stronger immune system and a higher disease-induced mortal-
ity rate in the sex that pays the lower cost, akin to previous non-sex-specific coevolutionary
modelling [28]. Under the influence of vertical transmission, we predict that evolution can
be driven to a state in which female hosts invest little in their immune system and pathogens
exhibit lower levels of disease-induced mortality in female hosts, relative to male hosts. This
result is similar to findings from sex-specific non-coevolutionary models [15]. The novel result
is that the combination of vertical transmission and host-pathogen coevolution can select for a
state in which pathogens exhibit a lower level of disease-induced mortality in heavily-defended
female hosts. In this way, we identify specific evolutionary pressures that could have led to the




We start with a population of N hosts classified according to their sex and disease status. At
time t, there are I f = I f (t) females infected with the pathogen and S f = S f (t) females not
infected. There are also Im = Im(t) males infected with the pathogen and S m = S m(t) males not
infected. All uninfected individuals are susceptible to infection, and all infected individuals are
also infectious.
Following the discussion of various mating functions in [62, 63], we model the host mating
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rate using the harmonic mean of the population sizes of females and males, given by
2(S f + I f )(S m + Im)
N
. (2.1)
The mating function is then multiplied by a per-capita birth rate, b. Assuming a one-to-one
birth sex ratio, the total rate at which new hosts enter either the susceptible female or suscepti-
ble male classes is
b(S f + I f )(S m + Im)
N
. (2.2)
Hosts in every class experience a per-capita background mortality rate µ, and hosts infected
by the pathogen experience an additional per-capita disease-induced mortality rate of α f in
females and αm in males. Infective females and infective males also recover at rates γ f and γm,
respectively, and return immediately to their associated susceptible class.
Horizontal transmission to susceptible sex-i hosts in class S i from infective sex- j hosts in
class I j occurs at a rate S iβi jI j. We also include the possibility of vertical transmission from
infective females to their offspring (as in [15]). If we assume that a proportion v of new hosts
created by infective females are born with the disease, then we now have a flow of newborns
into the infective female and male classes at a rate of
bvI f (S m + Im)
N
. (2.3)
This leaves us with newborns entering the susceptible female and male classes at a rate of
b(S f + (1 − v)I f )(S m + Im)
N
. (2.4)
The model description is summarized schematically in figure 2.1 and mathematically with
the following system of differential equations:
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Figure 2.1: A schematic diagram of the model. B f and Bm represent total birth rates given by
the sum of equations (2.3) and (2.4). Dashed lines indicate routes of horizontal transmission
while solid lines indicate routes of vertical transmission.
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+ S mβm f I f + S mβmmIm − (γm + αm + µ)Im. (2.5d)
As discussed in chapter 1 of this thesis, parameters are chosen so that there is a unique disease-
free equilibrium, which coincides with the trivial equilibrium, and a unique endemic equilib-
rium. To achieve this, it is assumed that b/2 , µ. Linear stability analysis of this system shows
that the disease-free equilibrium, where no infected individuals are present, is unstable when-
ever b/2 > µ. It is not possible to analytically find an endemic equilibrium of system (2.5),
i.e., an equilibrium where hosts of all classes are present. Instead, we use numerical simulation
to show that system (2.5) reaches an endemic equilibrium for a range of birth rates satisfying
b/2 > µ. However, if the birth rate becomes too large, the endemic equilibrium becomes un-
stable and the host population grows without bound. This indicates that there is a finite range
of birth rate values to explore in analyzing our model.
2.2.2 Evolutionary Dynamics
To study how pathogen disease-induced mortality and host immune investment respond to
selection, we assume that each faces a trade-off. The pathogen faces a trade-off between how
efficiently it is able to transmit itself and how quickly it kills its host. Following many previous
authors (e.g., [12, 8, 11]), we model the transmission constants βi j as functions of the pathogen
disease-induced mortality rates, α f and αm. In particular, we adapt the saturating functional
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form used in [28] to this sex-specific setting and write
βi j = βi j(α j) =
βmaxα j
α j + d
, (2.6)
where larger values of d > 0 indicate a slower rate of saturation. By making βi j independent of
i, we are assuming that females and males are equally susceptible to infection.
Hosts face a trade-off between investing resources in their immune system and their re-
productive success, as has been modelled by previous authors (e.g., [28, 19]). Hosts’ level of
immune investment is captured here by their sex-specific recovery rate, as in [28]. To relate the
total birth rate b to the recovery rates γ f and γm, we first suppose that the rate at which a female
gives birth decays exponentially with increasing immune investment and write it as bmaxe−k f γ f ,
where bmax is the maximal birth rate. The parameter k f > 0 measures the rate of decay of a fe-
male’s reproductive success due to increased investment in her immune system. For example,
female sex hormones enhance the immune system, which in turn reduces the likelihood of con-
ception and increases the chances of spontaneous abortion [64, 65, 66]. We also suppose that a
male’s probability of successfully mating with a female decays exponentially with increasing
immune investment and express it as e−kmγm . It could be that a male is rejected by a potential
female mate because he is not sufficiently attractive, and this decrease in reproductive success
is captured by the parameter km > 0. The total per-capita birth rate in the population is then
given by the product of the rate at which a female gives birth and the probability that a given
male is successfully able to mate with a female, bmaxe−k f γ f−kmγm . If we take a first-order approx-
imation to this exponential function, we can write bmaxe−k f γ f−kmγm ≈ bmax−bmaxk fγ f −bmaxkmγm.
We then interpret bmaxk f and bmaxkm as sex-specific reproductive costs to immune investment,
and relabel them c f and cm, respectively. We consider host immune system maintenance (as in
[28]) instead of immune system activation (as in [19]) so that hosts pay the reproductive cost to
immune investment regardless of whether they are in a susceptible or infective class. We can
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now relate b to the recovery rates γ f and γm via
b = b(γ f , γm) = bmax − c fγ f − cmγm. (2.7)
Equation (2.7) also generalizes the birth rate function used in [28] to this sex-specific setting.
Using an adaptive-dynamics approach [5, 6, 7], we can investigate how the pathogen and
host traits change over evolutionary time. As in [28] and [19], we apply this approach to both
the pathogen and host populations to study their coevolution. For the pathogen population, we
introduce a rare mutant-type pathogen with disease-induced mortality rates α̃ f in female hosts
and α̃m in male hosts. The numbers Ĩ f and Ĩm of female and male hosts, respectively, infected




bvĨ f (S̄ m + Īm)
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bvĨ f (S̄ m + Īm)
N̄
+ S̄ mβ̃m f Ĩ f + S̄ mβ̃mm Ĩm − (γm + α̃m + µ)Ĩm, (2.8b)
Overbars denote equilibrium levels of the resident host variables. We then apply a next-
generation matrix approach [30] to (2.8) to find a fitness function for the pathogen. In par-
ticular, we write the matrix J of first-order partial derivatives of (2.8) as J = F −V for matrices
F and V . The pathogen’s fitness Wα(α̃ f , α̃m, α f , αm) is then defined as the dominant eigenvalue
of the next-generation matrix FV−1 [30].
We follow a similar procedure for the host population by introducing a rare mutant-type
host with recovery rate γ̂ f in females and γ̂m in males. We denote the numbers of susceptible
and infective female mutant-type hosts as Ŝ f and Î f , respectively, and the numbers of suscep-
tible and infective male mutant-type hosts as Ŝ m and Îm, respectively. To account for the birth
rate of new mutant hosts, we take a first-order approximation by considering only mutant hosts
who are heterozygous for the mutation mating with resident (homozygous) wild-type hosts.
They will produce new offspring at a rate b̂ f for matings between mutant females and resident
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males, and at a rate b̂m for matings between mutant males and resident females. On average,
half of these matings will result in new hosts heterozygous for the mutation, so new susceptible
female or male mutant-type hosts are created at a total rate
b̂ f
2 (Ŝ f + (1 − v)Î f )(S̄ m + Īm) +
b̂m
2 (S̄ f + (1 − v)Ī f )(Ŝ m + Îm)
N̄
(2.9)
and new infective female or male mutant-type hosts are created at a total rate
b̂ f
2 vÎ f (S̄ m + Īm) +
b̂m
2 vĪ f (Ŝ m + Îm)
N̄
. (2.10)
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2 (S̄ f + (1 − v)Ī f )(Ŝ m + Îm)
N̄
(2.11a)
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2 (S̄ f + (1 − v)Ī f )(Ŝ m + Îm)
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(2.11c)





2 vÎ f (S̄ m + Īm) +
b̂m
2 vĪ f (Ŝ m + Îm)
N̄
+ Ŝ mβm f Ī f + Ŝ mβmm Īm − (γ̂m + αm + µ)Îm. (2.11d)
We then apply a next-generation matrix approach [30], as described above, to (2.11) to find a
fitness function Wγ(γ̂ f , γ̂m, γ f , γm) for the host.
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2.2.3 Methods of Analysis
Selection will move the pathogen’s disease-induced mortality in a direction given by the sign
of ∂Wα/∂α̃ f |α̃ f =α f in female hosts and ∂Wα/∂α̃m|α̃m=αm in male hosts. An endpoint of evolution










for i = f ,m. We then look for a continuously stable strategy (CSS) [22] of this process: an end-
point of evolution that both attracts nearby resident pathogen populations and resists invasion
by nearby mutant pathogen populations. If such a point attracts nearby resident populations,
then the matrix of first-order partial derivatives of the selection gradients of Wα must be neg-
ative definite. If this condition holds, we say the point is convergence stable [67, 68]. If the
point resists invasion by nearby mutant populations, then the matrix of second-order partial
derivatives of Wα must be negative definite. If this condition holds, we say the point is evolu-
tionarily stable [67, 68]. We can also define analogous conditions on the host fitness function,






m) that simultaneously satisfies the above
conditions on Wα and Wγ. Such a quadruple we call a coevolutionary continuously stable
strategy (coCSS) [28, 19].
In general, finding this quadruple cannot be done analytically. Instead, we use a Mat-
lab (version R2019a) algorithm, the code for which is available on the GitHub repository
at https://github.com/evanjmitchell/doctoral-thesis, to find the coCSS levels of
host recovery and pathogen disease-induced mortality numerically. This algorithm is based on
































(α̃ f ,α̃m)=(α f ,αm)
(2.13d)
will be convergence-stable evolutionary equilibria in the sense described above. We numer-
ically iterate this system until equilibrium has been reached to generate a candidate coCSS.
Finally, we use a centred finite-difference approximation to compute the matrices of second-
order partial derivatives of Wα and Wγ, evaluated at the candidate coCSS, and check that they
are negative definite. This is done by computing the eigenvalues of these matrices and con-
firming that they are all negative.
2.3 Results
2.3.1 No Sex-Specific Differences
Before exploring the full model (2.5), we consider two special cases. The first case is when
we strip away the sex differences from our model. In particular, we assume (i) that there is no
vertical transmission, (ii) that females and males pay the same reproductive cost of immune
investment (i.e., c f = cm = c), and (iii) that there are no sex-specific levels of recovery or
disease-induced mortality so that γ f = γm = γ and α f = αm = α and β f f = β f m = βm f =
βmm = β. We introduce new state variables S = S f + S m for the total number of susceptible
hosts and I = I f + Im for the total number of infective hosts. When this system is at the
endemic equilibrium, under these assumptions, we would expect to have S f = S m = S/2 and
I f = Im = I/2. Since the evolutionary analysis is performed when the resident system is at
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(S + I) + γI − S βI − µS (2.14a)
dI
dt
= S βI − (γ + α + µ)I, (2.14b)
where b = bmax−2cγ. We can then solve (2.14) to find a disease-free equilibrium (S , I) = (0, 0)
and an endemic equilibrium given by
S =
γ + α + µ
β
and I =
(γ + α + µ)(b − 2µ)
β[2(α + µ) − b]
. (2.15)
Linear stability analysis of the associated Jacobian matrix shows that the disease-free equilib-
rium is unstable when b/2 > µ, in which case the system moves towards the endemic equilib-
rium (2.15), and that the endemic equilibrium remains stable as long as b/2 < α + µ.
The evolutionary analysis proceeds as outlined above. Detailed calculations, presented in
Appendix A, show that we can analytically find the coCSS level of pathogen disease-induced
mortality to be α =
√
d(γ + µ), which matches the result found in the model used in [28]
(and in the Discussion of [19]) to analyze host-pathogen coevolution in the absence of host
sex differences. Solving for the coCSS level of host recovery is not possible analytically, but
numerical simulation suggests that there are two possible outcomes: an unstable equilibrium
characterized by an intermediate level of recovery, and a stable equilibrium characterized by
a higher level of recovery. Selection, then, will push the host-pathogen system towards this
stable equilibrium, corresponding qualitatively with predictions made in previous work [28].
We now relax the restriction that γ f = γm and α f = αm, and allow for sex-specific levels
of recovery and disease-induced mortality. We continue to assume that there is no asymmetry
between the sexes, i.e., both sexes pay the same reproductive cost of immune investment (c f =
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b(S f + I f )(S m + Im)
N
+ γmIm − S mβm f I f − S mβmmIm − µS m (2.16b)
dI f
dt
= S fβ f f I f + S fβ f mIm − (γ f + α f + µ)I f (2.16c)
dIm
dt
= S mβm f I f + S mβmmIm − (γm + αm + µ)Im, (2.16d)
where b = bmax − c(γ f + γm).
Analysis again proceeds as described above, with detailed calculations presented in Ap-
pendix A. We are able to show that the coCSS level of pathogen disease-induced mortality
is α f =
√
d(γ f + µ) in female hosts and αm =
√
d(γm + µ) in male hosts. This corresponds
qualitatively with results from previous authors that show that, in the presence of multiple
types of hosts, we expect the pathogen to evolve levels of disease-induced mortality specific
to each host type [15, 17]. The coCSS levels of host recovery cannot be found analytically,
and we instead use the numerical procedure described previously. Numerical results confirm
that the pathogen’s level of disease-induced mortality evolves towards that found analytically.
Moreover, the pathogen evolves the same level of disease-induced mortality in both female
and male hosts (i.e., α f = αm) and this matches the disease-induced mortality level predicted
in the previous result in the absence of any sex differences. This trend is also seen in the host
population, as our numerical results suggest that female and male hosts will evolve the same
level of recovery and that this communal level matches that found in the previous case with no
sex differences.
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Figure 2.2: Results from numerical simulation of the full model (2.5) across a range of repro-
ductive cost differences and vertical transmission rates. Solid black curves indicate boundaries
between regions containing qualitatively different evolutionary patterns, interpolated using nu-
merical results. Each point is split into two half-circles, with the area of the left half propor-
tional to the sex difference in disease-induced mortality rates and the right half proportional
to the sex difference in recovery rates. Red indicates a positive parameter difference, so that
higher values of the given parameter are found in females relative to males. Blue indicates a




To analyze the full model with sex-specific differences, we use the numerical method described
above. The results of this method are summarized in figure 2.2 and various aspects of this figure
will be discussed in the following paragraphs. We used a range of parameter values chosen to
satisfy the stability conditions presented previously, i.e., b/2 > µ but b cannot be so large that
the endemic equilibrium becomes unstable and the population grows without bound (see table
2.1).
Table 2.1: Ranges tested for the various model parameters, along with the qualitative effect of
an increase in a given parameter value on the results in figure 2.2.
Paramater Range Effect on Fig. 2.2 of Increasing Parameter Value
bmax {5, 10, 20} boundary curves pulled towards vertical axis
µ {1, 2, 4} boundary curves pulled towards horizontal axis
βmax {10, 20, 50} no noticeable effect
d {1, 2, 5, 10} right boundary curve pulled towards horizontal axis
The vertical axis of figure 2.2 has been partially explored in previous work on pathogen
evolution in response to vertical transmission in hosts [15], and our results on disease-induced
mortality evolution along this axis match those predictions. In particular, along the entire
vertical axis our model predicts that pathogens will evolve a lower level of disease-induced
mortality in female hosts relative to male hosts (figure 2.2). Our results also build on these pre-
dictions by including the coevolution of host recovery. For low rates of vertical transmission,
we see female hosts evolve a lower level of recovery than male hosts. However, for sufficiently
large rates of vertical transmission, the trend changes and we observe female hosts evolving a
higher recovery rate than male hosts.
Restricting attention to the horizontal axis of figure 2.2, there is no vertical transmission
and hosts pay a sex-specific reproductive cost to immune investment. Here, we find that the
host sex that pays the lower cost to immune investment will evolve the higher recovery rate.
Since the pathogen is now being cleared more quickly in this sex, there is selective pressure to
evolve a higher level of disease-induced mortality in this sex relative to the other.
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Figure 2.3: Evolutionary trends within each sex. Solid black curves are the same numerically
interpolated boundaries identified in figure 2.2. Panel A: The area of the left half-circle is
proportional to the coCSS level of female host disease-induced mortality, while the area of
the right half-circle is proportional to the coCSS level of male host disease-induced mortality.
Panel B: The area of the left half-circle is proportional to the coCSS level of female host
recovery, while the area of the right half-circle is proportional to the coCSS level of male host
recovery.
Finally, we investigate what happens when we move off of the axes and include both ver-
tical transmission and sex-specific reproductive costs to immune investment. Here, we see
the emergence of a region in which female hosts evolve a higher level of recovery while the
pathogen evolves a lower level of disease-induced mortality than it does in male hosts (upper-
left region in figure 2.2). This is a novel pattern not found in previous literature, and matches
the observations from clinical research showing a stronger immune system and lower level of
disease-induced mortality in female relative to male hosts across a wide range of infectious
diseases. Of particular note is that both vertical transmission and host-pathogen coevolution
are necessary conditions for the emergence of this pattern in our model.
In addition to looking at the evolutionary trends in one sex relative to the other, we can
also look at how disease-induced mortality and recovery rates are changing in each sex in-
dependently. These results are shown in figure 2.3. Panel A of this figure shows that as we
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increase the degree of sexual asymmetry via an increase in the vertical transmission rate, we
expect the pathogen’s disease-induced mortality rate to decrease in females while remaining
relatively unchanged in males. Increasing the degree of sexual asymmetry via an increase in
the reproductive cost difference, conversely, has a less noticeable effect on disease-induced
mortality rates in either sex. Panel B of figure 2.3 shows that we expect recovery rates in
both sexes to increase when we increase the vertical transmission rate. Furthermore, increas-
ing the reproductive cost difference has a more noticeable effect on recovery rates than it does
on disease-induced mortality rates. In particular, as we magnify the cost difference in favour
of one sex over the other, recovery rates will increase in the sex that pays the lower cost and
decrease in the sex that pays the higher cost.
Lastly, we can also recast these results in terms of more easily measurable quantities of
potential interest to public-health officials. In particular, we look at the effects on both the case
mortality rates, χ f in females and χm in males, and the expected lifetime of a host, defined as
the sum of the average amount of time for which they are in either the susceptible or infected
classes (see figure 2.4). Panel A of figure 2.4 shows that we expect the case mortality rate to be
lower in females than males for almost all parameter values explored, with a greater difference
for larger vertical transmission rates. As vertical transmission rates increase, we expect females
will invest more in their immune system which should lower their case mortality relative to
males. Panel B of figure 2.4 shows that females will have a longer expected lifetime than
males for almost all parameter values explored, with this difference being amplified by larger
rates of vertical transmission. Again, this is expected given our previous result of females
investing more in their immune system for higher rates of vertical transmission, as they will be
less likely than males to die prematurely due to the disease.
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Figure 2.4: Results from numerical simulation of the full model (2.5) recast in terms of more
easily measurable quantities of potential interest to public-health officials. Solid black curves
are the same numerically interpolated boundaries identified in figure 2.2. Panel A: The area of
each circle is proportional to the difference between female and male case mortality rates. Red
indicates a positive difference, so that case mortality is higher in females than in males. Blue
represents a negative difference, so that case mortality is higher in males than in females. The
black dashed line indicates where the case mortality rate is the same in both sexes, interpolated
using numerical results. Panel B: The area of each circle is proportional to the difference
between the expected lifetime of females and males. Red indicates a positive difference, so
that females have a longer expected lifetime than males. Blue indicates a negative difference,
so that males have a longer expected lifetime than females. The black dashed line indicates
where the expected lifetimes of both sexes are the same, interpolated using numerical results.
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2.4 Discussion
We have considered a model in which asymmetry was introduced between host sexes via a
difference in the reproductive cost to immune investment and the possibility of vertical trans-
mission in female hosts. The former is a direct cost to hosts, while the latter can be viewed
as an indirect cost to female hosts. In this way, we are treading on well-travelled ground, but
we place these effects in a coevolutionary setting in order to develop a more complete explana-
tion for the evolution of a greater immune response in females and increased disease-induced
mortality in males.
If we consider only the effects of sex-specific reproductive costs to immune investment,
our results predict that hosts and pathogens will coevolve to a state in which the sex that incurs
the lower cost will invest more heavily in their immune system and experience a higher rate
of disease-induced mortality. If a female host increases her immune investment due to a lower
reproductive cost, this reduces the pathogen’s fitness in female hosts relative to male hosts.
This puts selective pressure on the pathogen to increase its disease-induced mortality rate in
female hosts, which in turn puts pressure on female hosts to further increase their immune
investment. Eventually, this process will settle into a state where female hosts invest more
heavily in their immune system and the pathogen exhibits a higher disease-induced mortality
rate in female hosts. The same argument holds if male hosts instead pay the lower reproductive
cost to immune investment, mutatis mutandis. This result echoes previous work that studied
host or pathogen evolution in isolation. For example, [48] found that higher host immune
investment can select for higher pathogen disease-induced mortality, while [29] found that
higher pathogen disease-induced mortality can select for an increased host immune investment.
Our work establishes these outcomes as possible endpoints for host and pathogen populations
evolving in tandem.
When we include vertical transmission, we change the nature of the trade-off felt by fe-
male but not male hosts. For female hosts, immune investment now benefits both survival and
fecundity, where before it could only benefit survival. For low rates of vertical transmission,
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we predict decreased female immune investment since this added benefit is not yet enough
to outweigh the reproductive cost of immune investment. However, as the rate of vertical
transmission increases, the reproductive benefit to female immune investment increases. There
is then a threshold rate of vertical transmission past which female hosts will invest more in
their immune system than male hosts. Such a pattern is noted in [29], but is described as a
result of male immunity being more sensitive to changes in disease-induced mortality than fe-
male immunity. Here, we show that this outcome is not only a viable endpoint of selection via
coevolution of both hosts and pathogens, but also that this can be obtained as a result of consid-
ering the effects of female reproduction. Furthermore, this prediction matches the trend seen
in clinical studies across a wide range of infectious diseases, and provides a more complete
evolutionary explanation for this trend if the disease is able to be vertically transmitted.
Ewald [69] discusses the idea that vertical transmission should shift a host-pathogen pop-
ulation away from parasitism and towards a state of mutualism, similar to how beneficial mi-
crobes can evolve to increase their own fitness through increasing their host’s fitness [70]. Our
results support this hypothesis in female hosts for sufficiently large rates of vertical transmis-
sion. In our model, vertical transmission offers an additional transmission route to pathogens in
a female host, so that it would be a fitness benefit to the pathogen to reduce its level of disease-
induced mortality in order to survive longer inside a female host. This is a trend that has been
shown in previous work on non-sex-specific models [71] and non-coevolutionary sex-specific
models [15]. A reduction in disease-induced mortality will also confer a fitness benefit to fe-
male hosts. However, our results also suggest that this shift towards mutualism can be disrupted
by the effects of differential reproductive costs to immune investment between host sexes. In
particular, if female hosts incur a significantly smaller reproductive cost to immune investment
than male hosts, then evolution can maintain a parasitic relationship between pathogens and
female hosts for low levels of vertical transmission.
Our results also have potential implications for public health and personalized medicine.
First, selection favours higher levels of immune investment in both sexes as the vertical trans-
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mission rate grows. Second, regardless of which sex is investing more in their immune system
or has a higher disease-induced mortality rate, we generally expect females to experience a
lower level of case mortality than males. The sex-related difference in case mortality is most
apparent in the presence of large rates of vertical transmission, but we only ever predict in-
creased case mortality in females if they simultaneously incur a higher reproductive cost to im-
mune investment and the rate of vertical transmission is low. Finally, the pattern of increased
immune investment and decreased disease-induced mortality in female hosts could, in turn, ex-
plain the observed pattern of greater prevalence of autoimmune diseases in females [72, 73, 74].
If females mount a strong immune response even when a pathogen exhibits a relatively weak
rate of disease-induced mortality, due to the presence of strong vertical transmission, then they
may have a higher likelihood of mistakenly attacking their own cells instead of those of the
pathogen. If this is the case, we can speculate based on our model that implementing policies
aimed at reducing the rate of vertical transmission could lower the risk of autoimmune disease
in females, while still maintaining a lower level of case mortality than in males. More broadly,
our work contributes to a growing body of research (e.g., [24, 25, 26, 27, 15]) that shows that
host sex is an important component of conversations on infectious diseases.
Chapter 3
Prophylactic Host Behaviour Discourages
Pathogen Exploitation
3.1 Introduction
Mathematical study of infectious diseases has a long history that predates even the well-known
contributions of [1] and [2]. Mathematical study of the evolution of pathogens, however, is rel-
atively recent. One avenue of inquiry has explored the ways in which natural selection shapes
the virulent effects pathogens inflict on their hosts. Models have provided insight into the ways
in which various factors—such as parasite reproductive rates [75], host density [76], related-
ness among co-infecting pathogen strains [43], and multiple types of hosts [17]—modulate the
expressed level of virulence. A key prediction emerging from this body of work is that, in
many cases, selection acts to maximize the basic reproduction number [10, 19], i.e., the ex-
pected number of new infections caused by a single infective host [3]. In particular, adaptive
levels of pathogen virulence balance a trade-off between the average duration of infection and
the rate of disease transmission [12, 8]. As disease transmission rates slow, then, standard the-




Mathematics has also contributed to our understanding of the ways in which host traits
impact the evolution of pathogen virulence. Here, models have explored the effects of co-
evolution with innate host defences [19, 28], use of antibiotics [77], vaccines and vaccination
behaviour [49, 50], and other social factors related to hosts themselves [78]. It is this last
item—namely, the effect of host social behaviour on pathogen evolution—on which we focus
our attention in this paper. [79] discusses the idea of a “behavioural immune system” that
complements the standard physiological immune system in humans. This behavioural immune
system is comprised of various prophylactic measures, such as social distancing (e.g., avoiding
handshakes when greeting) or improved personal hygiene (e.g., hand washing), that individuals
may adopt to reduce the likelihood of infection [79]. Importantly, individuals can start and stop
these behaviours as often as desired (e.g., as in [33]), as opposed to measures like vaccination
that are, in a sense, irreversible.
Unfortunately, little is known about how hosts’ behavioural immune system impacts the
evolution of pathogens. What work has been done in this area predicts that prophylactic be-
haviour exhibited by hosts can select for higher pathogen virulence, assuming that the per-
ceived severity is higher for the more virulent strain and that the prophylactic measures are
more effective against the less virulent strain [33]. This work, however, considers short-term
evolutionary outcomes only, and does not consider the effects on host behavioural changes of
factors outside of social learning. In particular, the model of host behavioural dynamics in
[33] does not account for all the ways in which host demographics and disease dynamics could
affect the proportion of susceptible individuals engaging in prophylaxis. In order to assess
additional risks posed by pathogen evolution, then, different models are required.
We devise a model that tightly couples changes in the host’s behavioural immune system,
host demographics, and disease dynamics, in a way that allows us to make predictions about
the long-term evolution of pathogen host exploitation. We focus on pathogen exploitation in-
stead of virulence as we are considering sublethal disease effects and low-risk host behaviours
(e.g., hand washing). An important aspect of the host behaviours studied here is the relation
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between the utility cost associated with engaging in that behaviour, which may take many dif-
ferent forms, and the benefit in terms of a reduced likelihood of pathogen transmission. A
simple example would be more frequent hand washing, where an individual engaging in this
behaviour will benefit from a lower risk of contracting the disease at the cost of some extra time
out of their day and having to spend more money on soap than they would otherwise. Another,
more compelling, example is social distancing, which again reduces disease transmission but
can have much more severe social and economic costs as can be seen in the current COVID-19
pandemic [80]. We find that prophylactic behaviour uniformly reduces the pathogen’s exploita-
tion below the level expected in the absence of such behaviour. Furthermore, we argue that the
driving force behind our result is the modified nature of the transmission-recovery trade-off
faced by the pathogen as a result of the inclusion of host prophylactic behaviour.
3.2 Model
3.2.1 Disease Dynamics
We begin with a version of an endemic SIR model of infectious-disease dynamics [4] modified
in a way that separates a host population of total size N into two groups. Individuals in group
i = 0 are those who do not take prophylactic measures that limit (but do not completely prevent)
disease transmission, whereas those in group i = 1 do take such measures. Individuals in each
group are further subdivided according to their disease status. Let S i, Ii, and Ri denote the
number of individuals in group i who are susceptible to infection, infective, and recovered
from infection, respectively.
We assume that transmission is frequency-dependent. This is a common assumption when
modelling sexually transmitted diseases (STDs) since contacts between individuals in those
cases are generally not the result of random mixing [81, 82]. While we are not considering
STDs here, some prophylactic behaviours may create similar contact patterns within the popu-
lation. For example, in the case of social distancing, individuals intentionally limit their contact
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with others, and adding more people to the population may not greatly affect the average con-
tact rate. This would make frequency-dependent transmission a more appropriate model.
Each individual encounters another at a fixed rate and, given that an encounter is between
a susceptible and an infective, the likelihood of disease transmission depends on the groups to
which individuals belong. If βi j denotes the product of the probability of disease transmission
from a j-infective to an i-susceptible and the per-capita encounter rate, then S iβi jI j/N gives us
the total rate at which new infections are created in group i. Infective individuals recover at
a fixed per-capita rate, γ, independent of their group. As a result of recovery, individuals are
imbued with life-long immunity to future infection. Since we are considering sublethal disease
effects, we do not include disease-related mortality (virulence) in our model.
Individuals can also switch groups. For now, we use the constants τi j, φi j and ηi j to represent
the per-capita rates at which susceptible, infective, and recovered individuals, respectively,
switch from group j to i. We expand on the details surrounding group switching later. We can
summarize the description above using a system of differential equations. Scaling time so that
the background death rate is unity (i.e., one time unit is equivalent to the average lifetime of an
individual in the population), and matching birth and death rates, we get
dS 0
dt
= N − S 0
β00
N
I0 − S 0
β01
N






I0 − S 1
β11
N






I0 + S 0
β01
N






I0 + S 1
β11
N
I1 − (1 + γ)I1 − φ01I1 + φ10I0 (3.1d)
dR0
dt
= γI0 − R0 + η01R1 − η10R0 (3.1e)
dR1
dt
= γI1 − R1 − η01R1 + η10R0. (3.1f)
Here, we make the assumption that all newborns enter the S 0 compartment. While realistically
we might expect a fraction to enter the S 1 compartment (e.g., through cultural vertical trans-
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mission of prophylactic behaviours), the presence of the switching terms allows individuals in
the S 0 compartment to immediately move into the S 1 compartment if they choose to do so,
justifying our choice of modelling births as entering only the S 0 compartment.
Note that the differential equations in (3.1) sum to zero, and so total population size N is
constant. This, along with the fact that group membership among recovered individuals is of
no consequence, allows us to omit (3.1e) and (3.1f). We now use ui = S i/N and vi = Ii/N to
denote the fraction of susceptible and infective individuals, respectively, in group i. Similarly,
we use u = u0 + u1 and v = v0 + v1 to denote the total fraction of susceptible and infective






y(β01(1 − x) + β11x) + (1 − y)(β00(1 − x) + β10x)
]





y(β01(1 − x) + β11x) + (1 − y)(β00(1 − x) + β10x)
]
uv − (1 + γ)v. (3.2b)
We also track the fraction of susceptible and infected individuals taking prophylactic mea-
sures using x = u1/u and y = v1/v, respectively. Given this definition of x, we can derive
the following differential equation to describe how the proportion of susceptible individuals








group switching︷               ︸︸               ︷
τ01x + τ10(1 − x) +
infection of hosts not engaged in prophylaxis︷                               ︸︸                               ︷
(β00(1 − y)v + β01yv)(1 − x)x
− (β10(1 − y)v + β11yv)x(1 − x)︸                               ︷︷                               ︸
infection of hosts engaged in prophylaxis
. (3.2c)
The first term represents the fact that births increase the pool of individuals not engaging in
prophylactic measures, which in turn reduces the relative proportion of susceptible individuals
engaging in prophylactic measures. The τi j terms capture the effects of susceptible individuals
switching between engaging and not engaging in prophylaxis. The final two terms correspond
to infection. In one case, infection reduces the pool of individuals not engaging in prophylaxis
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and subsequently increases the relative proportion of individuals engaging in prophylaxis. Con-
versely, the proportion of susceptible individuals engaging in prophylaxis is directly reduced




group switching︷               ︸︸               ︷
φ01y + φ10(1 − y)−
infection of hosts not engaged in prophylaxis︷                              ︸︸                              ︷
(β00(1 − y) + β01y)(1 − x)uy
+ (β10(1 − y) + β11y)xu(1 − y)︸                              ︷︷                              ︸
infection of hosts engaged in prophylaxis
. (3.2d)
The first term represents the effects of infective individuals switching between engaging and
not engaging in prophylaxis. The latter two terms correspond to infection in the same vein as
in equation (3.2c).
Equations (3.2c) and (3.2d) capture dynamic features of the proportion of hosts engaged
in prophylaxis not found in previous work. The switching terms in the modelling undertaken
by [33] account for utility costs and benefits of prophylaxis, but neglect changes due to de-
mographics (births) and infection. Our equations, therefore, combine multiple processes to
establish a more realistic model of changing host behaviour.
We now return to the issue of group switching and the details surrounding the switching
terms τi j and φi j, ultimately replacing these constants with functions of x, y, and v. Individuals
do not always adhere to beneficial measures such as taking medications [83], exercise regimes
[84], or dietary restrictions [85], so we include group switching in our model to account for
these types of effects. Following [33], we use the replicator dynamic [34] to model the total
rate at which individuals move from one group to another. We assume that the decision to
switch groups is driven by utility, as discussed in [86]. Specifically, an individual’s utility will
be determined by their risk of infection less the utility cost of taking prophylactic measures.






= − (βi0(1 − y) + βi1y) v.
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Consequently, the utility of a susceptible individual adopting prophylactic measures is
− (β10(1 − y) + β11y) v − χ
where χ is the utility cost to engaging in prophylaxis. Infective individuals have no risk of
infection, so they only pay the utility cost of the prophylactic measure should they choose to
engage in it. Thus, −χ represents the utility of an infective individual engaging in prophylaxis.
A susceptible (resp. infective) individual will then choose to switch into a given group when
the utility of an individual in that group exceeds the utility of the average susceptible (resp.
infective) in the population. This replicator-dynamics model of switching gives us
− τ01x + τ10(1 − x) = kx(1 − x)[y(β01 − β11) + (1 − y)(β00 − β10)]v − kχx (3.3)
and
− φ01y + φ10(1 − y) = −kχy (3.4)
where k is a constant that reflects the rate at which individuals change their behaviour based
on the behaviour of others in the population (see Appendix B for a more detailed derivation of
equations 3.3 and 3.4). We note that our model of switching makes the simplification (made in
[33]) of assuming individuals have up-to-date information about the global state of the popula-
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+ (k + 1)x(1 − x)
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y(β01 − β11) + (1 − y)(β00 − β10)
]





y(β01(1 − x)y − β11x(1 − y)) + (1 − y)(β00(1 − x)y − β10x(1 − y))
]
u − kχy. (3.5d)
A sample trajectory of this system is shown in figure 3.1, panel A.
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Figure 3.1: Panel A shows a sample trajectory for the resident system (3.5). As described in the
main text, time has been rescaled so that one time unit is equivalent to the average lifetime of
an individual in the population. Panel B shows a bifurcation plot indicating the cost threshold
(dotted red line) at which the endemic equilibrium without prophylaxis (dashed blue line) and
the endemic equilibrium with prophylaxis (solid black line) undergo an exchange of stability.
Parameter values are: κ = 5, βmax = 70.4721, k = 5.1745, and ε = 0.5951. The initial condition
used in panel A was: u = 0.7, v = 0.3, x = 0.01, and y = 0.01.
Note that, if no individual in the population takes prophylactic measures, then x = y = 0
and we recover the standard endemic SIR model (Appendix C). When some fraction of the
population takes prophylactic measures, however, standard predictions of the SIR model may
or may not hold. The linear stability analysis presented in Appendix C shows that the endemic
equilibrium without individuals engaging in prophylaxis remains stable as long as











where R0 = β00/(1 + γ) is the basic reproductive number [3] of the system in the absence of
prophylactic measures. Below this threshold, the cost to taking prophylactic measures is low
enough that the system moves towards a new endemic equilibrium (û, v̂, x̂, ŷ) at which some
non-zero fractions of susceptible and infective individuals adopt prophylactic measures (figure
3.1, panel B). It is this new endemic equilibrium that will frame the evolutionary model we
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pursue in the next section.
3.2.2 Evolutionary Dynamics
We consider the evolution of the level of pathogen exploitation of its host, denoted ξ > 0.
Exploitation affects disease transmission, with a greater ξ value corresponding to a greater βi j.
To reflect this, we now write βi j(ξ) where
βi j(ξ) =
βmax (1 − ε)i+ jξ
κ + ξ
. (3.7)
In words, we are treating βi j as an increasing function of ξ that saturates at a value of βmax(1 −
ε)i+ j, where ε is the probability that the prophylactic measures prevent disease transmission.
We assume that prophylactic measures taken by individuals fail independently, so (1−ε)2 gives
the probability that the disease is transmitted between two individuals engaging in prophylaxis.
The rate at which transmission saturates is controlled by κ > 0, with larger values of this
constant corresponding to a reduced rate of saturation.
Exploitation also affects recovery. To reflect this assumption, we write γ(ξ), where γ(ξ) =
cξ for a constant c with units of inverse time (the exploitation level ξ is dimensionless). Without
loss of generality, we take c = 1. Here, increased exploitation acts to reduce the expected
duration 1/(1 + γ(ξ)) of an infection. This penalty of larger ξ, then, trades off against the
transmissibility benefits described above. Previous authors have either assumed (or shown) that
such trade-offs exist, though they are often mediated by disease-related mortality [10, 13, 11] or
viral load [14]. Here, we follow [15] and [16] by assuming the trade-off faced by the pathogen
involves recovery. For example, through increased viral load making it more likely that the
pathogen is detected by the host’s immune system, or increased exploitation leading to more
antigens presented on the surfaces of target cells.
We use an adaptive dynamics approach to model the evolution of pathogen exploitation
under the primary influence of natural selection ([5, 6, 7]; and see [19, 15, 30] for examples
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specifically related to virulence evolution). We introduce a rare mutant pathogen with exploita-
tion trait ξm into a resident pathogen population with exploitation trait ξ. It is assumed that the
resident system has reached equilibrium prior to introducing the mutant, that there is no co-
infection, and that the prophylactic measures are equally effective at preventing transmission
of both strains.
Let vm denote the fraction of individuals in the population infected with the mutant strain.
While the mutant is rare, its dynamics are well approximated by
dvm
dt
= [ym(β01(ξm)(1 − x̄) + β11(ξm)x̄) + (1 − ym)(β00(ξm)(1 − x̄) + β10(ξm)x̄)]ūvm
− (1 + γ(ξm))vm, (3.8a)
where overbars denote equilibrium values of the respective variables. As we do with the resi-
dent population, we can also track the proportion of individuals infected with the mutant strain
engaging in prophylaxis. Denoting this proportion by ym, we can describe its dynamics by
dym
dt
= −[ym(β01(ξm)(1 − x̄)ym − β11(ξm)x̄(1 − ym))
+ (1 − ym)(β00(ξm)(1 − x̄)ym − β10(ξm)x̄(1 − ym))]ū − kχym. (3.8b)
If the mutant strain becomes common and the mutant-free equilibrium becomes unstable, we
say that the mutant has successfully invaded the resident population. Provided the system
is sufficiently close to an evolutionarily steady state, a mutant who successfully invades will
become the new resident [5].
Since vm does not appear in (3.8b), we can first solve for the equilibrium value ȳm of ym,
substitute that value into (3.8a), and study (3.8a) alone. If the right-hand side of (3.8a) is
positive (resp. negative), the mutant invades (resp. is eliminated) because it is favoured (resp.
disfavoured) by natural selection. The sign of the right-hand side of (3.8a) is the same as the
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represents an average transmission rate taking into account the different groups of susceptible
and infective individuals. W then has a clear biological interpretation, made in previous work
[19], in terms of the basic reproductive number of the mutant strain. In particular, an infection
with the mutant strain lasts an average of 1/(1 + γ) time units and an average of βavgū new
infections are created during this time. If this quantity is larger than one (resp. smaller than
one), then the mutant population will grow (resp. shrink). Writing W as we have done in
equation (3.9) also highlights the transmission-recovery trade-off described above, captured
through the βavg and γ terms. Through the ȳm terms, the pathogen is also able to influence
whether a new infection occurs in an individual engaging or not engaging in prophylaxis. We
can, therefore, use W as an invasion fitness function in the adaptive dynamics analysis, even
though the derivation of the function proceeded in a non-standard way.
Following the discussion above, the direction of evolution of ξ that is favoured by nat-
ural selection is given by the sign of ∂W/∂ξm|ξm=ξ. Consequently, the selective process is at






An equilibrium value ξ̄, i.e., one that satisfies condition (3.10), may or may not be stable. If
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and we say that ξ̄ is evolutionarily stable (sensu [20]). A sufficient condition for either type of
stability is obtained by replacing the weak inequality with a strict one. It is the strict sufficient
versions that we use here. When ξ̄ is both convergence stable and evolutionarily stable, we say
it is a continuously stable strategy (CSS) [22].
3.3 Results
3.3.1 Simple Cases
There are two special cases that can be analyzed with relative ease. The first special case
assumes the cost of prophylaxis exceeds the threshold χc. In this case, no one in a population
supporting the resident endemic disease is adopting prophylactic measures and so x̄ = ȳ = 0.









The mutant strain is then able to invade (resp. is eliminated) if W(ξm, ξ) exceeds (resp. is less
than) unity; equivalently, if R0(ξm) exceeds or is less than R0(ξ). More importantly, the CSS
level of exploitation, ξ̄, will maximize R0(ξ) and so ξ̄ =
√
κ. This will serve as a benchmark
against which more general results will be compared.
The second special case assumes that prophylactic measures are cost-free, i.e., χ = 0. Since
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χ < χc, the system moves towards an endemic equilibrium where some non-zero proportions
of susceptible and infective individuals are engaging in prophylaxis. While the replicator dy-
namics predict that all individuals will begin adopting prophylactic measures in the absence
of cost, the terms noted in equations (3.2c) and (3.2d) relating to demographics and disease
dynamics counteract this effect. This will result in the evolution of intermediate levels of the
proportions of susceptible and infective individuals engaging in prophylaxis. Under the as-
sumption of zero cost, the distribution of the mutant strain, captured by ȳm, does not depend on
the mutant exploitation level and so the pathogen is not able to influence whether new infec-
tions occur in individuals engaging or not engaging in prophylaxis. In this case, the selection
gradient simplifies and results in a CSS of ξ̄ =
√
κ (see Appendix D). This is the same result as
the benchmark established in our first special case, despite the presence of individuals taking
prophylactic measures. Absence of cost, it seems, decouples the pathogen’s evolution from the
evolution of host behaviour due to the pathogen no longer being able to influence the relative
proportions of infections in individuals engaged or not engaged in prophylaxis.
3.3.2 Evolution Near the Critical Cost
In general, the model cannot be explored analytically. However, there are certain analytical
results we can derive for cost values other than those discussed in the previous section. In
particular, we can show that for any cost value, there is a unique stable equilibrium value of ym
on the interval [0, 1]. Moreover, we can show that the derivative of this equilibrium value with
respect to the mutant exploitation ξm is always positive, and that this complicates the relation-
ship between pathogen exploitation and transmissibility (see Appendix E for a derivation of
these results). This leads to a change in the evolutionarily stable level of pathogen exploitation
away from that which would be expected in the absence of prophylaxis.
If we are near the critical cost χc we can derive quasi-analytic results to predict the direction
of this change in the CSS value of ξ. When the cost χ is slightly below its critical threshold χc,
we can approximate the CSS exploitation level as ξ̄ ≈
√
κ + σ(χ − χc) where χ − χc < 0 and σ
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If σ is positive (resp. negative), then ξ̄ is below (resp. above) the benchmark value of
√
κ. As
equation (3.14) shows, whether we are above or below this benchmark depends on how small
changes in cost lead to small changes in the proportion of susceptible individuals engaged in
prophylaxis which, in turn, lead to changes in the selection gradient acting on exploitation (see
Appendix F for a derivation of equation 3.14).
We can show with a quasi-analytic approach that equation (3.14) is always positive. Our
evidence relies on first choosing feasible values of our parameters. In particular, we need
R0 > 1. If R0 > 1, then we need also to choose the probability ε > 1k+1
R0
R0−1
, thus ensuring that
χc > 0. To ensure that ε < 1, we then need to choose k > 1R0−1 .
Using feasible parameters and working to zeroth order in χ − χc, we use the computer
algebra software (CAS) Maple (version 2019.1) to investigate the sign of σ as described in
equation (3.14). We find that the requirement that R0 > 1 necessarily restricts our choices
of maximal transmissibility, βmax, to values that lie above the curve traced out by (1 +
√
κ)2
(figure 3.2, panel A). The CAS shows that nullclines of the partial derivative in (3.14) never
exceed the (1 +
√
κ)2 curve for the wide range of feasible parameters we investigated (figure
3.2, panel B). Thus, the sign of σ does not change provided the R0 > 1 restriction is met.
Moreover, test points show that the sign of σ itself is positive when feasible model parameters
are chosen. Based on CAS investigations described in Appendix G, then, we conclude that,
just below the critical cost, selection acts to reduce the CSS level of host exploitation exhibited
by the pathogen.
3.3.3 Evolution for Arbitrary Cost
Our results can be extended numerically for costs that are possibly much smaller than the
critical value, χc, using a Matlab (version R2019a) procedure available on the GitHub repos-
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A B
Figure 3.2: Panel A shows the curve χc = 0 (dashed grey) overlaying the curve R0 = 1 (solid
black), and the region of parameter space where χc > 0 and R0 > 1. Dotted grey curves
represent the roots of the partial derivative on the right-hand side of equation (3.14) and panel
B shows that these all occur on or below the black and dashed grey curves (note that vertical
dotted grey lines are an artifact of jump discontinuities). Choosing parameter values in the
region above the curves in panel A results in the partial derivative on the right-hand side of
equation (3.14) being negative, as noted in panel B. The implication is that the parameter σ is
positive and so pathogen exploitation will decrease relative to the benchmark level of
√
κ close
to the cost threshold χc.
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itory at https://github.com/evanjmitchell/doctoral-thesis. We build the proce-
dure around the observation that locally asymptotically stable equilibrium solutions to dξ/dt =
(∂W/∂ξm)|ξm=ξ are also convergence-stable evolutionary equilibria as defined by conditions
(3.10) and (3.11), respectively. As a result, numerical iteration of this differential equation
can be used to find candidate CSS strategies. The evolutionary stability of candidate CSS
strategies can be confirmed with a centred finite-difference approximation of (3.12). Since the
error is on the order of the square of the distance between ξ values used in the approximation,
we consider any value within this error to satisfy the ESS condition (3.12).
The results of our numerical procedure confirm that the benchmark CSS level of ξ̄ =
√
κ
is obtained when χ = 0 and χ = χc. Second, numerical results confirm the reduction in the
CSS level of pathogen exploitation for χ slightly smaller than χc. Third, and most important,
numerical results indicate that the CSS exploitation level ξ̄ changes in a simple way as cost is
reduced from its critical value to its natural lower limit at zero (figure 3.3). In particular, as
cost is reduced ξ̄ decreases monotonically from the benchmark value until it reaches a mini-
mum. Once at the minimum, the direction of selection changes and ξ̄ increases monotonically,
ultimately returning to the benchmark when cost disappears.
This pattern holds for a wide range of parameter values chosen to satisfy the conditions
described in the previous section. Specifically, we investigate four different values of κ: κ = 0.1,
κ = 1, κ = 10, and κ = 100. For each of these values, we choose five values of βmax above the
(1 +
√
κ)2 threshold: βmax = (1 +
√
κ)2 + 5, βmax = (1 +
√
κ)2 + 10, βmax = (1 +
√
κ)2 + 50,
βmax = (1 +
√
κ)2 + 100, and βmax = (1 +
√
κ)2 + 500. We then choose five values of k
(k = 1/(R0 − 1) + 5, k = 1/(R0 − 1) + 10, k = 1/(R0 − 1) + 50, k = 1/(R0 − 1) + 100, and
k = 1/(R0−1)+500) and five values of ε spread evenly between the thresholdR0/((k+1)(R0−1))
and 1, for a total of 500 combinations of parameter values.
Although the decline in the CSS value of exploitation shown in figure 3.3 appears modest,
recall that one time unit is equivalent to the average lifetime of an individual in the population.
This means that the change in the duration of infection as ξ̄ changes is on the order of years. For
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Figure 3.3: Plots of the CSS level of pathogen exploitation found using the numerical procedure
described in the main text. Panel A contains sample results for κ = 0.1, panel B for κ = 1,
panel C for κ = 10, and panel D for κ = 100. Inset figures show the equilibrium values of the
epidemiological variables u, v, x, and y. The cost values presented are all below the critical
cost threshold χc. In all cases, the CSS level of exploitation is lower than the benchmark value
ξ̄ =
√
κ, plotted as a dashed black line, observed in the absence of prophylaxis.
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example, if the average lifespan of an individual in the population is 79 years, then a decrease
from ξ̄ = 1 to ξ̄ = 0.86 (as seen in figure 3.3, panel B) corresponds to an increase in the duration
of infection of approximately three years.
3.4 Discussion
We study the impact of measures taken by hosts to limit disease transmission. Here, the will-
ingness among hosts to engage in these prophylactic behaviours responds to changing utility
costs and benefits. We focus on long-term evolution of a pathogen, defined by successive muta-
tions until an equilibrium state is reached [86], alongside the rapid evolution of host behaviour.
We find that when prophylactic behaviour among hosts occurs, pathogen host exploitation is
always lower than it is in the absence of prophylaxis. Moreover, we find that stable exploita-
tion is lowest for an intermediate frequency of prophylactic behaviour among hosts (indirectly,
intermediate cost of prophylaxis).
This study contributes to the growing body of work that shows host behaviour, in general,
influences pathogen evolution. Much of this work has considered vaccination behaviour, in
particular, and has described both beneficial and detrimental evolutionary outcomes. In the case
of human papillomavirus (HPV), for example, theoretical work predicted HPV vaccination
will select for higher levels of virulence [50]. By contrast, empirical evidence suggests that
vaccination can actually limit the ecological opportunity open to certain HPV types [87]. In
keeping with the mixed nature of results, [51, 52] find that the direction of selection acting on
pathogen virulence depends on the mechanism by which vaccination works.
More closely related to the current study are the conclusions of [33]. They show that
host prophylactic behaviour in response to an endemic disease can allow for the invasion of a
pathogen strain that is more virulent than the resident, and that the conditions for such a result
are an increased perceived severity for the more virulent strain and more effective prophylactic
measures against the less virulent strain. While our model considers sublethal disease effects
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and does not explicitly include virulence, the positive relationship between pathogen exploita-
tion and virulence allows us to predict that such an outcome cannot occur in our model. This
is a result of the fact that our benchmark result, established in the absence of prophylactic
behaviour, is our worst case scenario. For example, consider a mutant pathogen with an ex-
ploitation level ξ >
√
κ. When the cost is above its critical value so that no one is engaging
in prophylaxis, then this mutant cannot invade a resident population at the CSS ξ̄ =
√
κ. If
we then decrease the cost below its critical value so that individuals begin to take prophylactic
measures, the CSS exploitation level decreases away from ξ̄ =
√
κ and so the mutant is still
unable to invade the resident population.
The discrepancy between our prediction and those of [33] is due to the differences in how
we model the dynamics of host behaviour. In addition to looking at actual risk instead of
perceived risk (as in [33]), the evolution of host behaviour in our work is not governed solely by
the replicator dynamics. Our model consists of additional terms to represent the effects of births
and infection on the proportion of individuals engaging in prophylactic behaviour. Moreover,
we track the proportion of infective individuals taking prophylactic measures, which adds an
extra layer of complexity to the relationship between pathogen exploitation and transmissibility
(Appendix E). These key differences are missing from previous work [33] and lead us to the
conclusion that, for all feasible sets of parameter values, we expect a decrease in pathogen
exploitation away from the benchmark value found in the absence of prophylactic behaviour.
To obtain a more direct comparison to previous work, future iterations of our model should
explicitly include virulence and explore the subsequent predictions on pathogen evolution.
To get some intuition into the decrease in exploitation that we find in this paper, we need
to understand two things. In the absence of prophylaxis, standard theory (e.g., [19, 15, 16])
predicts that increased pathogen exploitation results in a decrease in the duration of infection
and an increase in transmission, leading to a balance between these two competing effects
at evolutionary equilibrium. In our model, increasing exploitation still reduces the duration
of infection, but it affects transmission in a more complicated way. This more complicated
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effect on tranmissibility disrupts the balance that would be achieved in standard models. As
we show in Appendix E, there is a benefit to increased exploitation through a direct increase
in transmission, but also a marginal cost through increased exposure to the host behavioural
immune system. In fact, the marginal cost is indirect as it results in fewer mutant infections
in hosts not engaging in prophylaxis (i.e., smaller 1 − ȳm). Ultimately, this added cost tips the
scales in favour of lower pathogen exploitation.
We have already pointed to specific differences between our work and similar work of
others [33]. While those differences will undoubtedly affect the model predictions, the intuition
developed above suggests a more concrete explanation for the contrast is possible. In particular,
[33] do not expose mutant infectives to host prophylactic behaviour in a way that differs from
resident infectives. Granted, [33] do allow for the efficacy of prophylaxis to differ between
resident and mutant strains, but the host landscape looks the same from both resident and
mutant perspectives in that model. In our model, mutant infections in individuals engaging in
prophylaxis happen in different proportions than resident infections (i.e., ȳm , ȳ in general).
Simply put, the host landscape in our model differs meaningfully between resident and mutant
infectives.
Arguably, our main result is reminiscent of other pathogens that control host behaviour for
their own gain. While our model pathogens are not directly controlling hosts like the pathogen
Ophiocordyceps unilateralis does with the ant Camponotus leonardi [88] (or Schistocephalus
solidus with the stickleback fish Gasterosteus aculeatus [89], or Leucochloridium paradoxum
with the snail Succinea putris [90]), one might speculate that ours indirectly manipulate the
hosts’ economic agency. This suggests that there may be some cryptic parasite manipulation
to further investigate.
As with any modelling endeavour, we have made some simplifying assumptions to reduce
the mathematical complexity of our model. For example, we have assumed that individuals
instantly update their behaviour when receiving new information about the progression of the
disease. In reality, there is a time delay between receiving information and deciding to modify
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behaviour. Previous work has studied the effects of including a delay in the form of waning
immunity either independently [91] or together with a delay in the form of a latent period fol-
lowing infection [92], and found that this can create periodicity in the model solutions. Other
work has also investigated the effects of these delays on effective vaccination strategies [93].
Future work could extend our model to include the lag in information gain and behaviour mod-
ification, with the expectation that this would cause oscillations in the predicted exploitation
level.
One could also relax the assumption that individuals sample from all other individuals in the
population when deciding whether or not to take prophylactic measures. Epidemic models have
previously been extended to include spatial structure through the use of networks, with different
types of networks providing qualitatively different predictions [94]. Others have studied the
interaction between network models and host heterogeneities in the case of sexually transmitted
diseases [95], and the effects of adaptive networks where individuals may build and sever
connections during the progression of a disease [96]. Networks could be incorporated here to
explore the decoupling of social interactions related to disease transmission and those related
to information transmission. Based on previous work [97], it is expected that this decoupling
could lead to a lower level of pathogen exploitation.
It is tempting to use our evolutionary predictions to inform public-health policy. While
pathogen exploitation does reach a minimum value for an intermediate level of cost of pro-
phylaxis, our results (figure 3.3) also show that lowering the cost even farther below this level
leads to fewer infections even if those infections are from a more exploitative pathogen strain.
Moreover, the pathogen’s exploitation is always below the level predicted in the absence of
individuals engaging in prophylactic behaviour. There is a balance, then, between the level of
cost that is optimal for minimizing prevalence and the level optimal for minimizing pathogen
exploitation. It is important to recognize that efforts to minimize the cost of prophylaxis will
result in a pathogen strain that is more exploitative of its host than it otherwise might be. More
broadly, our work suggests that conversations about disease management and infection should
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be more inclusive towards the effects of human behaviour.
Chapter 4
Cooperation between Related Coinfecting
Pathogen Strains in Multiple Types of
Hosts
4.1 Introduction
A theoretical framework was presented in [43] for studying the evolution of disease-induced
mortality among groups of coinfecting pathogen strains. This framework has its underpinnings
in the Price equation [98, 99], and links tools from evolutionary game theory and kin selection
theory in an epidemiological setting. Starting with a definition of fitness as the basic reproduc-
tive number R0 [3] of a focal pathogen strain, the disease-induced mortality rates of both the
focal pathogen and its group are assumed to depend on the genotype of the individual pathogen
strains [43, 44]. From this interpretation, the evolutionary equilibrium level of disease-induced
mortality of a focal pathogen strain will depend on its genetic relatedness to its coinfecting
group. The more related is a group of coinfecting pathogens, the greater is the incentive to
reduce their individual disease-induced mortality rate to prolong the duration of infection of
the whole group [43]. However, this framework is only developed in epidemiological models
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with a single type of host. How do these ideas extend to situations where multiple types of
hosts are present, in which fitness is not defined in such a straightforward way?
Analyses of models with multiple types of hosts usually follow an adaptive-dynamics ap-
proach [5, 6, 7]. A resident host-pathogen system is assumed to have reached an equilibrium
state, after which a mutant pathogen strain is introduced and tracked in the population. The
fitness of this mutant strain can be defined as the instantaneous growth rate of the host popu-
lation infected with the mutant strain [17] or, equivalently, as the basic reproductive number
[3] of the mutant strain, which must take into account all types of hosts and is defined as the
dominant eigenvalue of the next-generation matrix [17, 30, 31, 32]. Fitness is then maximized
within each type of host, striking a balance between the pathogen’s rate of transmission and its
duration of infection [17].
Here, we investigate how these tools and ideas on pathogen evolution in multiple types of
hosts connect to those from kin selection theory discussed in a single-host setting in [43, 44].
To do this, we present a theoretical framework for studying the evolution of disease-induced
mortality among groups of related coinfecting pathogen strains in multiple types of hosts (e.g.,
females and males; large and small; juveniles, young adults, and adults). We discuss how
fitness can be defined as either the instantaneous growth rate of a focal pathogen lineage or
as the basic reproductive number R0 [3] of that focal lineage, and establish the equivalence
between these two measures. We then study how the inclusion of genetic relatedness [43, 44]
affects fitness and provide a biological interpretation of the resulting evolutionary equilibrium
conditions. In general, we find that pathogens must balance the direct individual and indirect
group benefits of increased transmission against the associated direct individual and indirect
group costs of shorter duration of infection, within each type of host. This reflects the ideas of
Hamilton [45] that greater relatedness should push for greater cooperation among a group of
individuals.
Following the presentation of the theoretical framework, we work through two examples
to illustrate using these ideas in practice. The first example considers a model of an infectious
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disease circulating in a population of juvenile and adult hosts. The second example extends
the framework to a model in which hosts coevolve with pathogens, in the setting of a sexually
transmitted infection circulating in a population of female and male hosts. We then conclude
with some summarizing remarks.
4.2 Theoretical Framework
Suppose we have a population of hosts categorized into n different types. Hosts are further clas-
sified according to their disease status. Individual hosts are infected by a group of pathogens
made up of various genetically related strains. The disease-induced mortality rate of an in-
dividual pathogen strain will be expressed as a vector α, where each element αi represents
the pathogen’s disease-induced mortality rate in a host of type i. The average disease-induced
mortality rate of a group of infecting pathogens will be expressed as a vector αg, where each
element αgi represents the average disease-induced mortality rate of a group of pathogens in-
fecting a host of type i. In what follows, we assume that pathogens face a trade-off between
transmission and disease-induced mortality, whereby increased disease-induced mortality will
result in increased transmission but also a decreased duration of infection. This is a common
trade-off modelled by other authors in the case of multiple pathogen strains [43], coevolution
with hosts [28, 19], and vector-transmitted diseases [11]. The trade-off faced by pathogens
need not involved disease-induced mortality, though, and could instead involve other traits
such as the degree to which pathogens exploit their host’s resources [15], viral load [14], or
pathogen growth rate [16].
To study the evolution of pathogen disease-induced mortality, we begin by assuming that
there is a host-pathogen system that has reached equilibrium. We then fix attention on a spe-
cific pathogen strain and track its lineage in the population. The disease-induced mortality rate
of this focal strain can be expressed as the vector α̃. As before, the elements α̃i of this vector
represent the disease-induced mortality rate of the focal strain in a host of type i. An infecting
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pathogen group containing this focal strain will have an average group disease-induced mor-
tality rate expressed as the vector α̃g, where each element α̃gi represents the average disease-
induced mortality rate of a pathogen group infecting a host of type i and containing the focal
strain. We can express the densities of all types of hosts infective with a pathogen group con-
taining the focal strain, at time t, as the n× 1 column vector Ĩ = Ĩ(t). The dynamics of the focal
pathogen strain are then approximated by the linear system
dĨ
dt
= [F(α̃, α̃g,α,αg) − V(α̃, α̃g,α,αg)]Ĩ, (4.1)
where F and V are n × n matrices.
The matrix F contains all terms related to the production of new pathogens (e.g., transmis-
sion). In particular, the entry fi j in the ith row and jth column of F represents the rate at which
hosts of type j infective with the focal pathogen strain create new infections in hosts of type i
susceptible to infection. By this definition, all entries of F must be non-negative, i.e., F must
be a non-negative matrix.
The matrix −V contains all terms related to transitions between infective classes of hosts
infective with the focal pathogen strain (e.g., juvenile infective hosts maturing into adult infec-
tive hosts), as well as terms related to loss of hosts infective with the focal strain (e.g., recovery,
natural mortality, disease-induced mortality). In particular, the entry vi j in the ith row and jth
column of −V represents the sum of the rate at which hosts of type j infective with the focal
strain transition to hosts of type i infective with the focal strain, and the rate at which hosts
of type i leave their corresponding infective class. If Ĩi represents the density of hosts of type
i infective with the focal pathogen strain, then loss of individuals from class Ĩi will occur, to
first-order in the frequency of the focal strain, at a rate proportional to Ĩi. Terms representing
the loss of hosts infective with the focal strain, then, will appear only on the main diagonal of
the matrix −V . Entries off the main diagonal of −V must represent only transitions into class Ĩi
from class Ĩ j, j , i, and so must be non-negative. Such a matrix, where all entries off the main
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diagonal are non-negative, is called a Metzler matrix. Since F is non-negative, the entries off
the main diagonal of the matrix F − V must be non-negative and so F − V is also a Metzler
matrix.
We can then find a positive constant c such that (F − V) + cI is a non-negative matrix,
where I is the n × n identity matrix. Specifically, we can choose any c > |min
i
vii|, where vii
represents the ith entry on the main diagonal of −V . For any such c, the entries on the main
diagonal of (F − V) + cI will be strictly positive, and so (F − V) + cI is a non-negative matrix.
We now consider the graph associated with the matrix (F − V) + cI. Nodes in this graph
represent the densities of hosts of each type infective with a pathogen group containing the
focal strain. The entries of (F − V) + cI represent directed connections between these nodes,
with the i jth entry describing the creation of new infections in type-i hosts by infected type- j
hosts (e.g., transmission) and the transition of infected type- j hosts to infected type-i hosts
(e.g., maturation). Assuming that a host of type i can either be infected by a host of type j or
by a host of type k, who can themselves be infected by a host of type j (or possibly by a host of
some other type, forming an “infection chain” that eventually links to a host of type j), there
will always be a path leading from node j to node i in the graph of (F − V) + cI. Hence, the
graph of (F − V) + cI is irreducible [100]. Furthermore, since the entries on the main diagonal
of (F − V) + cI are strictly positive, loops (i.e., paths of length one) will exist from node i to
itself. This means that the greatest common divisor of the lengths of the paths of (F − V) + cI
must be one. Together with the fact that the graph is irreducible, this allows us to say that
(F − V) + cI is a primitive matrix [100].
The Perron-Frobenius Theorem for primitive non-negative matrices tells us that (F−V)+cI
has a dominant real eigenvalue Λ+c > 0 with associated real positive left and right eigenvectors
wT and u, respectively [100]. Moreover, all other eigenvectors of (F −V) + cI must be negative
[100]. In other words, the spectrum of the matrix (F − V) + cI, defined as the set of all
eigenvalues of the matrix, is contained within the circle of radius Λ + c centred at the origin in
the complex plane. It has been shown [101] that shifting a matrix by a constant multiple c of the
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identity matrix preserves the eigenvectors of that matrix, but shifts the spectrum of the matrix
by the constant c. This means that the spectrum of the matrix F−V is contained within the circle
of radius Λ + c centred at the point (−c, 0) in the complex plane. Importantly, the dominant
eigenvalue of the matrix F −V is Λ, with associated positive left and right eigenvectors wT and
u, respectively.
We express the evolutionary equilibrium of (4.1) as a vector α∗, where each element α∗i
represents the equilibrium level of the trait in a type-i host. At evolutionary equilibrium, all
pathogen strains must exhibit the same disease-induced mortality rate in each type of host,
i.e., α̃ = α = α∗. If all pathogens exhibit the same rate of disease-induced mortality, then
the average disease-induced mortality rate of a group of infecting pathogens will match this
equilibrium level, i.e., α̃g = αg = α∗. By definition, at this evolutionary equilibrium, the focal
pathogen population must not be changing and so
0 = (F∗ − V∗)Ī, (4.2)
where 0 represents the n × 1 zero column vector, Ī represents the vector of equilibrium den-
sities of infective hosts of each type evaluated at the evolutionary equilibrium, and F∗ and V∗
represent the matrices F and V evaluated at the evolutionary equilibrium, respectively.
Equation (4.2) shows that I is a positive right eigenvector for the matrix F − V . Since the
only positive eigenvectors of (F − V) + cI are those associated with the dominant eigenvalue,
and since eigenvectors are preserved by shifting the matrix by cI, we can conclude that u = I
is a right eigenvector associated with the dominant eigenvalue Λ of F − V . The positive left
eigenvector wT associated with Λ must satisfy wT (F − V) = ΛwT . As long as the densities
of infected hosts are still changing (i.e., Λ , 0), we can rewrite this as wT = (wT/Λ)(F − V).
Since the i jth entry of F − V represents the net number of new type-i infected hosts created by
a type- j infected host, this allows us to interpret the ith element of wT as the reproductive value
of a type-i infected host in the sense that wTi represents the average number of infected hosts of
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any type created by a type-i infected host, discounted by the growth rate Λ of the infected host
population.
We can then define a fitness function for the focal pathogen lineage in one of two ways.
The first is to define it as the growth rate of the infected host population, given by the dominant
eigenvalue Λ of the matrix F − V . Equivalently, we can express this in terms of the associated
left and right eigenvectors and define fitness as W1(α̃, α̃g,α,αg) = wT (F − V)u. The second
way is to follow a standard adaptive-dynamics approach [5, 6, 7] and define fitness as the
average number of new infections created by a host infected with the focal pathogen strain.
This can be expressed as the dominant eigenvalue ΛNGM of the next-generation matrix FV−1 or,
equivalently, in terms of the associated left and right eigenvectors wTNGM and uNGM, respectively
[30]. The left eigenvector associated with the dominant eigenvalue of the next-generation
matrix is the same as the left eigenvector of the dominant eigenvalue of the matrix F − V ,
i.e., wTNGM = w
T , while the right eigenvector associated with the dominant eigenvalue of the
next-generation matrix is given by uNGM = Fu. We can then express the fitness of the focal
pathogen strain as W2(α̃, α̃g,α,αg) = wT FV−1(Fu).
While these two fitness functions have different interpretations, they are related to one
another [18]. In particular, if we multiply W1 by the dominant eigenvalue ΛNGM of the next-
generation matrix and use the fact that the left and right eigenvectors of the next-generation
matrix associated with ΛNGM are wT and Fu, respectively, we get:
ΛNGMwT (F − V)u = wT FV−1(F − V)u = wT FV−1(Fu) − wT (Fu) = W2 − 1, (4.3)
where we have assumed that the eigenvectors wT and Fu have been rescaled so that wT (Fu) =
1. Dividing both sides of (4.3) by ΛNGM , 0 and using the fact that W2 can be equivalently
expressed as ΛNGM, we have that




Equation (4.4) shows that W1 is positive (resp. negative) if and only if W2 is greater than one
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(resp. less than one).
To find the evolutionary equilibrium α∗, we adapt the procedure used in [43, 44] and con-
sider the genotypic values xi and x̃i of a typical pathogen strain and the focal strain, respectively,
in a host of type i. We write the genotypic value of a typical pathogen strain as the vector x and
that of the focal pathogen strain as the vector x̃. The disease-induced mortality rate of a typical
strain, α, will depend on the pathogen’s genotype in each type of host, x. Similarly, the disease-
induced mortality rate of the focal strain, α̃, will depend on the focal pathogen’s genotype in
each type of host, x̃. One can translate the genotypic value into a continuous phenotype by
assuming that the latter is a product of the presence of a genetic allele and the rate at which that
allele changes the phenotype, as is done in [43]. The equilibrium α∗ is then found by solving
the system dWi/dx̃|x̃=x=x∗ = 0, where x∗ represents the genotype of a pathogen strain at the evo-
lutionary equilibrium α∗ [43, 44]. From equation (4.4), we have dW1/dx̃ = (1/W22 )(dW2/dx̃)
and so dW1/dx̃ = 0 if and only if dW2/dx̃ = 0. This means that we can analyze either W1 or
W2 and arrive at the same evolutionary equilibrium. Using W1, and the fact that the dominant





























where all terms are evaluated when α̃i = αi = α̃gi = αgi = α
∗
i . If we divide both sides of

























is the genetic relatedness of the focal pathogen strain to the infecting group
of pathogens to which it belongs [43, 44].
To interpret equation (4.6) biologically, we identify two terms. Term I measures the change
in two types of benefits conferred to the focal pathogen for increasing its disease-induced mor-
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tality rate: a direct benefit of increased personal transmission and an indirect benefit, weighted
by the focal pathogen’s relatedness to its group, of increased group transmission. Similarly,
term II measures the change in two types of costs incurred by the focal pathogen for increas-
ing its disease-induced mortality rate: a direct cost of decreased personal duration of infection
and an indirect cost, weighted by the focal pathogen’s relatedness to its group, of decreased
group duration of infection. Equation (4.6) then says that, at evolutionary equilibrium, these
benefits and costs must balance out within each type of host. Moreover, the more related is
the focal pathogen to its infecting group, the more the indirect benefit and cost will affect the
evolutionarily stable trait value α∗.
4.3 Illustrative Examples
4.3.1 Example 1: Infections in Age-structured Host Populations
Our first example considers an infectious disease circulating in a population of hosts classified
according to their age. Such models have been studied in the cases of tuberculosis [102] and
pertussis [103], and have been used to explore the effects on evolution of different contact
patterns between susceptible and infected individuals [104]. At time t, there will be I j = I j(t)
juvenile hosts infected with the disease and S j = S j(t) juvenile hosts susceptible to infection.
There will also be Ia = Ia(t) adult hosts infected with the disease and S a = S a(t) adult hosts
susceptible to infection. All infected hosts are also infective.
Adult hosts will produce juvenile offspring at a per-capita rate b. We assume that juvenile
hosts cannot reproduce, but they will mature into adults at a per-capita rate m. Both juveniles
and adults will experience a natural mortality rate µ.
Infected juvenile hosts will transmit the disease to susceptible juveniles at a per-capita rate
S jβ j and to susceptible adults at a per-capita rate S aβ j. Infected adult hosts will transmit the
disease to susceptible juveniles at a per-capita rate S jβa and to susceptible adults at a per-capita
rate S aβa. Juvenile hosts will recover from infection at a per-capita rate γ j and they will die
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due to the infection at a per-capita rate αg j , where αg j is an average disease-induced mortality
rate across the group of infecting pathogen strains. Similarly, adult hosts will recover from
infection at a per-capita rate γa and they will die due to the infection at a per-capita rate αga ,
where αga is an average disease-induced mortality rate across the group of infecting pathogen
strains.
The model is summarized by the following system of differential equations:
dS j
dt
= b(S a + Ia) + γ jI j − S j
(
β jI j + βaIa
)
− (m + µ)S j (4.7a)
dS a
dt
= mS j + γaIa − S a
(
β jI j + βaIa
)





β jI j + βaIa
)
− (γ j + m + µ + αg j)I j (4.7c)
dIa
dt
= mI j + S a
(
β jI j + βaIa
)
− (γa + µ + αga)Ia. (4.7d)
To study the evolution of disease-induced mortality, we assume pathogens face a trade-
off between transmission and recovery, as previous authors have done [43, 11, 10, 13]. To
capture this, we follow [43] and treat transmission and recovery as functions of the focal
pathogen’s disease-induced mortality rate in juvenile hosts, α j, and adult hosts, αa. We then
write β j = β j(α j), βa = βa(αa), γ j = γ j(α j), and γa = γa(αa). We suppose that (4.7) has
reached an endemic equilibrium. While it is not possible to find and analyze the stability of
this equilibrium analytically, numerical simulation suggests that an endemic equilibrium exists
and is stable for some sets of parameter values. We then track a focal pathogen lineage with
disease-induced mortality rates α̃ j and α̃a in juvenile and adult hosts, respectively. An infect-
ing group of pathogens containing this focal strain will have an average group disease-induced
mortality rate of α̃g j in juvenile hosts and α̃ga in adult hosts. If we use the vector Ĩ = (Ĩ j, Ĩa)T to
denote the densities of juvenile and adult hosts infected with a group of pathogens containing
the focal strain, then we can approximate the dynamics of the focal strain with the following






S̄ jβ̃ j S̄ jβ̃aS̄ aβ̃ j S̄ aβ̃a
︸          ︷︷          ︸
F
−
γ̃ j + m + µ + α̃g j 0
−m γ̃a + µ + α̃ga




where β̃ j = β j(α̃ j), β̃a = βa(α̃a), γ̃ j = γ j(α̃ j), γ̃a = γa(α̃a), and overbars denote equilibrium
densities hosts. Given that all model parameters are positive, the entries off the main diagonal
of F − V will be non-negative and so F − V is a Metzler matrix.
In order to investigate the evolutionary equilibrium condition given in (4.6), we first need
to find the left and right eigenvectors wT and u, respectively, associated with the dominant
eigenvalue of the matrix F − V . As discussed previously, at evolutionary equilibrium, the left
eigenvector wT can be interpreted as the reproductive value of infected juvenile and adult hosts,
while the right eigenvector u can be interpreted as the equilibrium numbers of infected juvenile
and adult hosts. The left eigenvector wT is found by solving
0 = wT (F − V), (4.9)
where F and V are evaluated at the evolutionary equilibrium α∗ = (α∗j, α
∗
a). From this, we get












where wa is the reproductive value of a focal pathogen in an infected adult host, asterisks denote
traits evaluated at the evolutionary equilibrium α∗, and overbars denote equilibrium numbers
of hosts. The right eigenvector u is found by solving
0 = (F − V)u (4.11)
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where Īa is the equilibrium number of adult hosts infected with the focal pathogen strain.
We can now use these eigenvectors to analyze the evolutionary equilibrium condition (4.6).




γ′j + r j


















where primes denote first derivatives and r j represents the relatedness of the focal pathogen
strain to its coinfecting group in a juvenile host. On the left-hand side of (4.13), we have
the benefit to the focal pathogen for increasing its disease-induced mortality, measured as the
rate of change of transmission relative to the transmission rate itself. On the right-hand side
of (4.13), we have the cost, both direct and indirect, to the focal pathogen for increasing its
disease-induced mortality rate, measured as the rate of change of the duration of infection
relative to the duration of infection itself. This cost has a compounding effect attached to it to
capture the fact that if the focal pathogen increases its disease-induced mortality in a juvenile
host to the point where it kills the juvenile host before it is able to mature into an adult, it will
miss out on all of the possible infections it could have created in that matured juvenile host.
Term I in (4.13) measures the rate at which an infected juvenile host matures into an infected
adult host relative to the rate at which an infected juvenile host is able to create infections in
susceptible adults. If a juvenile host infected with the focal pathogen is able to create new
infections in susceptible adults much faster than it matures into an infected adult itself, then
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this decreases the compounding effect on the cost to the focal pathogen. Term II in (4.13)
measures the potential number of adult infections that could be created by infecting juveniles
and waiting for them to mature relative to the potential number of adult infections that could be
created in susceptible adults. If there are fewer juvenile hosts who will survive to mature into
adults after being infected by the focal pathogen strain, then this will increase the compounding
effect on the cost to the focal strain for increasing its disease-induced mortality rate.
The effect of increased relatedness can be seen analytically in (4.13). In particular, if the fo-
cal pathogen strain is more related to its coinfecting group in a juvenile host, this will increase
the cost associated with increased disease-induced mortality. To maintain the equilibrium bal-
ance, (4.13) then says that evolution will push for reduced disease-induced mortality in order
to reduce the transmission rate β∗j. This effect is depicted graphically in figure 4.1. The slope of
the solid curve is the ratio of the rate of change of transmission to the rate of change of duration
of infection, while the slope of the dashed and dotted lines is given by the ratio of transmission
to duration of infection, multiplied by the compounding effect in brackets in (4.13). These
slopes are equal at the intersection point marked by the black square. The dotted line shows
that, for increased relatedness, the evolutionary equilibrium occurs at a lower rate of transmis-
sion and a higher duration of infection, both of which are achieved by reducing disease-induced
mortality.



























where ra is the relatedness of the focal pathogen to its coinfecting group in an adult host.
The numerator of the fraction in the brackets in (4.14) can be simplified slightly by making the
observation that, at equilibrium, neither the infected juvenile nor infected adult populations can
be growing or shrinking. In particular, when one juvenile host leaves the infected compartment
at the end of the duration of infection of a juvenile host, it must be replaced simultaneously by
4.3. Illustrative Examples 75
Figure 4.1: Graphical depiction of the effect of increasing relatedness between the focal
pathogen strain and its coinfecting group. The slope of the solid curve is given by β′j/D
′
j,
where D j is the duration of infection of a juvenile host. The slope of the dashed and dotted
lines is given by β j/D j multiplied by the compounding effect given in brackets in (4.13). Equa-
tion (4.13) is satisfied when these two slopes are equal in magnitude, which occurs at the point
of intersection marked by the black square. Increasing relatedness r j will increase D′j, which
will drag the intersection point farther right along the horizontal axis. This new intersection
point is characterized by reduced transmission and increased duration of infection, achieved
via a reduction in disease-induced mortality.
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a new infected juvenile host. This replacement infected juvenile can be created either by an
infected juvenile host or by an infected adult host. The total number of new juvenile infections





. Similarly, the total number of new juvenile infections created by an infected adult






. The total number of
new juvenile infections created over the duration of infection of a juvenile host is then given by
the sum of these two terms and must be equal to one at evolutionary equilibrium. This allows
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∗
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β∗aS̄ a + mγ∗j + µ + α∗j + mβ∗aS̄ j




As in the juvenile equilibrium condition, the left-hand side of (4.15) measures the benefit to
the focal pathogen for increasing its disease-induced mortality rate and the right-hand side
measures the associated cost. Term I in (4.15) measures the total number of new infected
juvenile hosts created by an infected adult host over the duration of infection of a juvenile
host. Term II in (4.15) measures the total number of new infected adult hosts created by an
infected adult over the duration of infection of an adult host, both from direct infection of
susceptible adults and maturation of infected juveniles into infected adults. As with juvenile
hosts, increased relatedness of the focal pathogen strain to its coinfecting group in adult hosts
will push for reduced disease-induced mortality.
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4.3.2 Example 2: Sexually Transmitted Infections
For our second example, we study a system where hosts and pathogens are allowed to coevolve.
We consider a sexually transmitted infection (STI) circulating in a population of female and
male hosts. Hosts are further classified according to their disease status. At time t, there are
I f = I f (t) female hosts infected with the disease and S f = S f (t) female hosts susceptible to
infection. Similarly, there are Im = Im(t) male hosts infected with the disease and S m = S m(t)
male hosts susceptible to infection. All infected hosts are also infective.
Females will have an average of M = M(N f ,Nm) mating events with males, where N f is
the total number of female hosts and Nm is the total number of male hosts. As discussed in
[62, 63], a common functional form for M uses the harmonic mean of the numbers of female
and male hosts, i.e.,
M(N f ,Nm) =
2N f Nm
N f + Nm
. (4.16)
Mating events will lead to the production of new offspring at a per-capita rate b. Assuming a
one-to-one birth sex ratio, the total birth rate of both female and male hosts is given by
bN f Nm
N f + Nm
. (4.17)
Female and male hosts will also experience a per-capita natural mortality rate µ.
As in previous models of STIs (e.g., [62, 105, 106]), transmission of the disease between
females and males will occur at a rate proportional to the average number of mating events






M(N f ,Nm) = S f
2βm
N f + Nm
. (4.18)
Similarly, transmission from infected females to susceptible males will occur at a frequency-






M(N f ,Nm) = S m
2β f
N f + Nm
. (4.19)
Female hosts can then recover from infection at a rate γ f , in which case they are again suscep-
tible to infection, or die due to the disease at a rate αg f . Similarly, male hosts can recover at a
rate γm, in which case they are again susceptible to infection, or die due to the disease at a rate
αgm . As discussed previously, we assume that hosts are infected by a group of pathogens and
so the disease-induced mortality rates αg f and αgm represent averages across infecting pathogen
groups.
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N f + Nm
I f − (γm + µ + αgm)Im. (4.20d)
To study host evolution, we first suppose that female and male hosts have some level η f and
ηm, respectively, of investment in their immune system. A host’s level of immune investment
will affect both the rate at which it clears an infection, γ f or γm, and their birth rate, b. To reflect
this, we now write γ f = γ f (η f ), γm = γm(ηm), and b = b(η f , ηm). In general, increased immune
investment will result in a faster rate of clearance at the cost of a lower birth rate, as has been
modelled by previous authors [19, 28]. Our goal is then to find the evolutionary equilibrium
level of female and male host immune investment η∗f and η
∗
m, respectively.
We start by assuming that system (4.20) has reached an endemic equilibrium where hosts of
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all classes are present in some numbers. As with the previous example, finding this equilibrium
is not possible analytically, but numerical simulation suggests that it exists and is stable for
some sets of parameter values. We then consider a host lineage where females and males have
a level of immune investment η̂ f and η̂m, respectively, different from that of the equilibrium
host population. Female hosts of the focal lineage will clear an infection at a rate γ̂ f = γ f (η̂ f ),
while male hosts of the focal lineage will clear an ifnection at a rate γ̂m = γm(η̂m). All hosts
of the focal lineage will have a per-capita birth rate given by b̂ = b(η̂ f , η̂m). The numbers
of susceptible and infected female hosts of this focal lineage will be denoted by Ŝ f and Î f ,
respectively. Similarly, the numbers of susceptible and infected male hosts of this focal lineage
will be denoted by Ŝ m and Îm, respectively. If we use the vector Ĥ = (Ŝ f , Ŝ m, Î f , Îm) to denote
the number of hosts of the focal lineage in each disease category, then the dynamics of the
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+ µ 0 −γ̂ f 0
0 2β f Ī fN̄ f +N̄m + µ 0 −γ̂m
2βm Īm
N̄ f +N̄m
0 γ̂ f + µ + αg f 0
0 2β f Ī fN̄ f +N̄m 0 γ̂m + µ + αgm




where overbars denote equilibrium levels of the respective variables. Finding the dominant
eigenvalue of the matrix Fh − Vh is computationally intensive, so we instead work with the
dominant eigenvalue ΛNGMh of the next-generation matrix FhV
−1
h [30] and define host fitness
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was Wh(η̂ f , η̂m, η f , ηm) = ΛNGMh . Differentiating Wh with respect to the level of female host im-
mune investment η̂ f , and evaluating at η̂ f = η f = η∗f and η̂m = ηm = η
∗
m, gives the evolutionary




∂γ̂ f /∂η̂ f
G f (γ̂ f , γ̂m, β f , βm, αg f , αgm)
, (4.22)
for a function G f . Similarly, we can differentiate Wh with respect to male host immune invest-
ment η̂m, evaluate at η̂ f = η f = η∗f and η̂m = ηm = η
∗
m, and find the evolutionary equilibrium





Gm(γ̂ f , γ̂m, β f , βm, αg f , αgm)
, (4.23)
for a function Gm. Equations (4.22) and (4.23) show that, at evolutionary equilibrium, hosts
must balance the benefit of increased clearance rate against the cost of decreased reproduction.
Importantly, pathogen evolution will affect host evolution through the functions G f and Gm.
To study the evolution of pathogen disease-induced mortality, we first assume that sys-
tem (4.20) has reached an endemic equilibrium where hosts of all classes are present in some
numbers. Furthermore, as in the previous example, we assume that pathogens face a trade-off
of increased transmission and decreased duration of infection for increased disease-induced
mortality. To capture this, as in [43], we treat transmission and recovery as functions of indi-
vidual pathogen disease-induced mortality, i.e., β f = β f (α f ), βm = βm(αm), γ f = γ f (α f ), and
γm = γm(αm), where α f and αm are the disease-induced mortality rates of a pathogen strain
in female and male hosts, respectively. We then track a focal pathogen lineage with disease-
induced mortality rate expressed as the vector α̃ = (α̃ f , α̃m), where α̃ f and α̃m are the focal
pathogen’s disease-induced mortality rates in female and male hosts, respectively. A group
of infecting pathogens containing this focal strain will have an average group disease-induced
mortality rate expressed as the vector α̃g = (α̃g f , α̃gm), where α̃g f and α̃gm are the average group
disease-induced mortality rates in female and male hosts, respectively. If we use the vector
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Ĩ = (Ĩ f , Ĩm)T to denote the densities of hosts infected with a group of pathogens containing the












︸                     ︷︷                     ︸
Fp
−
γ̃ f + µ + α̃g f 00 γ̃m + µ + α̃gm




where β̃ f = β f (α̃ f ), β̃m = βm(α̃m), γ̃ f = γ f (α̃ f ), γ̃m = γm(α̃m), and overbars denote equilibrium
densities of hosts.
To analyze the evolutionary equilibrium condition (4.6), we first need to find the left and
right eigenvectors wT and u, respectively, associated with the dominant eigenvalue of the ma-
trix Fp − Vp. As discussed previously, at equilibrium, this dominant eigenvalue is zero and
the associated left and right eigenvectors can be interpreted as reproductive value and equi-
librium numbers of individuals infected with the focal pathogen strain, respectively. The left
eigenvector wT is found by solving
0 = wT (Fp − Vp) (4.25)











where asterisks denote traits evaluated at the evolutionary equilibrium α∗ = (α∗f , α
∗
m) and wm
is the reproductive value of the focal pathogen strain in a male host. The right eigenvector u is
found by solving
0 = (Fp − Vp)u (4.27)
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where Īm is the equilibrium number of male hosts infected with the focal pathogen strain.
We can then construct the evolutionary equilibrium conditions from (4.6). The equilibrium




γ′f + r f




where primes denote first derivatives and r f is the relatedness of the focal pathogen strain to
its coinfecting group in a female host. As in the previous example, the left-hand side of (4.29)
represents the benefit to the focal pathogen strain for increasing its disease-induced mortality,
while the right-hand side represents the associated direct and indirect costs. The more related
is the focal pathogen strain to its coinfecting group, the higher will be the cost and so evolution
will push for reduced disease-induced mortality to maintain the benefit-cost balance.





γ∗m + µ + α
∗
m
γ∗f + µ + α∗f2β∗m
N̄ f +N̄m
S̄ f
︸           ︷︷           ︸
I
γ∗m + µ + α∗m2β∗f
N̄ f +N̄m
S̄ m
︸            ︷︷            ︸
II
, (4.30)
where rm is the relatedness of the focal pathogen strain to its coinfecting group in male hosts.
Term I represents the inverse of the number of new infections created in female hosts over the
duration of infection of a female host, while term II represents the inverse of the number of new
infections created in male hosts over the duration of infection of a male host. At equilibrium,
both of these quantities must be one so that the infected host population is neither growing nor









As with female hosts, male hosts must balance the benefits of increased disease-induced mor-
tality against the associated direct and indirect costs. The more related is the focal pathogen to
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its coinfecting group, the lower will be the equilibrium disease-induced mortality rate. Unlike
in the previous age-structured model example, here, the evolutionary equilibrium conditions
are symmetric between the two host types.
4.4 Discussion
Here, we have presented a general framework for studying the evolution of disease-induced
mortality among groups of related coinfecting pathogen strains in a host population classified
into different types. Two examples were discussed to show how this general framework can be
used in practice.
The first example considers an infectious disease circulating in a population of hosts split
into juveniles and adults. Our theoretical framework shows that the evolutionary equilibrium
conditions are asymmetric between host types. Pathogens in adult hosts must balance their
direct benefit with their direct and indirect costs. However, in juvenile hosts, pathogens have
an extra risk of killing their host before it matures into an adult, missing out on any infections
it could have caused in the matured juvenile host. This creates an asymmetry between the
equilibrium conditions of juvenile and adult hosts.
The second of these examples explores host-pathogen coevolution in the case of a STI cir-
culating in a population of female and male hosts. A pathogen strain that increases its disease-
induced mortality rate will gain a direct benefit of increased personal transmission, but it will
also incur both a direct cost of a higher likelihood of being cleared by the host’s immune sys-
tem and an indirect cost of a reduced duration of infection for the entire coinfecting pathogen
group. As in [43], these benefits and costs must balance out at evolutionary equilibrium. In
this scenario, the equilibrium conditions are symmetric between host types. Furthermore, the
degree of relatedness between coinfecting pathogen strains will also influence the coevolution
of host immune investment.
In both examples, we find that increased relatedness among a group of coinfecting pathogen
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strains will select for cooperation as individual strains reduce their disease-induced mortality
rate in order to prolong the duration of infection of the group, in keeping with the ideas put
forth by Hamilton [45] on inclusive fitness. Such an effect of relatedness has been shown by
Frank [43] in single-host models. Experimental studies on the Microbotryum violaceum [107]
and Microbotryum lychnidis-dioicae [108] plant fungi have shown that competition to infect a
host is fiercer between less related strains. Theoretical work on spatially structured populations
[97] has shown that increased pathogen dispersal will result in lower relatedness among strains
on a given patch of hosts, which will, in turn, select for greater virulence. While our framework
does not include spatial structure, it does confirm that reduced relatedness among strains should
select for higher disease-induced mortality.
Our theory has its underpinnings in the Price equation [109, 110], which provides a general
mathematical framework for understanding the effects associated with natural selection. The
Price equation has been extended previously to describe problems in evolutionary epidemi-
ology concerning the evolution of multiple pathogen strains [98], the evolutionary effects of
demographic stochasticity [99], and relatedness among coinfecting pathogen strains [43, 44].
In each of these cases, a methodology based on the Price equation provides an interpretation
of the biological forces governing pathogen evolution under natural selection. Our work adds
to this literature by extending these ideas to situations involving multiple types of hosts and,
potentially, coevolution between hosts and pathogens.
One important limitation of this framework is that we are not able to make any conclusions
about evolutionary stability [20, 22] or convergence stability [21]. Doing so would require
specifying the functional relationship between transmission and clearance and disease-induced
mortality, as well as establishing the dependence of pathogen relatedness to disease-induced
mortality. However, by sacrificing the ability to determine stability criteria, we are able to
make conclusions about the biological forces shaping evolutionary equilibria in more general
settings.
Our work also provides a more straightforward approach to studying pathogen coinfec-
4.4. Discussion 85
tion. Most analyses of coinfecting strains involve explicitly modelling complex within-host
pathogen dynamics [39]. They take into account such things as pathogen exploitation of host
resources [40], the production of molecules used as a public good by the group of coinfecting
pathogens [41], and the interaction between pathogens and host lymphocytes [42], to make
predictions about the evolution of disease-induced mortality. Our framework gives up some
of these details by capturing the within-host dynamics by the genetic relatedness of coinfect-
ing pathogen strains, but this allows us to make more general predictions about how pathogen
strains should interact with one another without the need for additional modelling assumptions.
Much of this previous work on coinfecting pathogen strains has also focused on the evo-
lution of pathogen virulence. Throughout this paper, we have been careful to refer to the
evolution of pathogen disease-induced mortality instead of virulence. Virulence is generally
defined to be the reduction in host fitness due to infection by the pathogen [10, 11, 111, 23].
Host fitness is comprised of two components: reproduction and survival. In our first example
on an age-structured model, pathogens only affect host survival and not host reproduction, so
it would be appropriate to refer to disease-induced mortality as virulence. However, in the
second example, pathogens affect both host survival and reproduction. Host survival is af-
fected directly by pathogen disease-induced mortality. Host reproduction is affected indirectly
through the effect of disease-induced mortality on host clearance. Higher disease-induced mor-
tality will push for hosts to invest more in their immune systems, taking away resources from
reproduction and lowering their reproductive success. This adds an additional dimension to
the effect of the pathogen on host fitness, and means that pathogen virulence is not necessarily
equivalent to pathogen disease-induced mortality. Depending on the model under study, then,
the evolutionary consequences of pathogen relatedness on virulence may be more complex




In this thesis, I have provided three pieces of evidence to support the claim that host-pathogen
coevolution and multiple types of hosts are important forces governing real-world populations
and that they lead to theoretical predictions not found in research that excludes either of these
effects. From a practical point of view, these new predictions can provide additional perspective
for conversations on the spread and management of infectious diseases.
I began, in Chapter 2, with a model of host-pathogen coevolution in a scenario where hosts
are categorized into female and male groups. The goal was to develop a theoretical explanation
of the differences in immune investment and disease-induced mortality observed between the
sexes across a wide variety of infectious disease data. Previous authors have studied how
differences in host immune investment [24, 25, 27] or pathogen disease-induced mortality [15]
could have evolved, but without considering the effects of coevolution this does not provide a
complete explanation for how both hosts and pathogens could have evolved to the point that is
observed in clinical data. I have contributed to this discussion by showing that coevolutionary
forces, responding to inherent differences between types of hosts due to vertical transmission
and sex-specific costs to immune investment, can lead to a state in which female hosts invest
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heavily in their immune systems while pathogens exhibit increased disease-induced mortality
in male hosts.
One feature of the model used in Chapter 2 is that host type is fixed. In Chapter 3, I
relax this assumption by instead considering a model where hosts are able to change their
type. In particular, hosts are categorized according to whether or not they choose to engage
in prophylactic behaviour (e.g., hand washing, social distancing) to reduce their likelihood of
transmitting an infectious disease. While both hosts and pathogens are evolving in this sce-
nario, they are doing so on different time scales. I modelled host evolution using the replicator
dynamic [34] and assumed that host behaviour reached a quasi-equilibrium before considering
the evolution of the pathogen. The main finding was that accounting for these multiple types
of hosts and their coevolution with pathogens gives rise to the prediction that the level of the
pathogen’s exploitation of its host will be lower than it would be in the absence of these effects.
Both of the models in Chapters 2 and 3 considered only a single pathogen strain. In Chapter
4, I relax this assumption and instead consider coinfection of hosts by multiple, genetically
related pathogen strains. Much of the literature on coinfecting pathogen strains uses complex
models of within-host pathogen dynamics [39] to take into account such things as pathogen
exploitation of host resources [40], the production of molecules as a public good used by
pathogens [41], and interactions between pathogens and host immune cells [16]. Instead, I
provide a framework based on kin selection theory [43] for analyzing these kinds of models
in the presence of multiple types of hosts. As an illustrative example, I consider a scenario in
which hosts are coevolving with pathogens, and show how the relatedness between coinfecting
pathogen strains can affect the evolution of host immune investment and how this, in turn, feeds
back into affecting pathogen evolution.
The nature of the topics under investigation in this thesis makes it challenging to compare
results to empirical observations. Data sets on costs and levels of immune investment, on the
proportion of a population engaging in prophylactic behaviours at any given time, or on the
relatedness among a group of coinfecting pathogen strains are not readily available or easily
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measured. Instead, I have chosen to focus on theoretical predictions. Experimental studies
could be designed, though, to test these predictions. For example, one could survey groups of
individuals over the course of a flu season and ask them to report on how often they engaged
in some prophylactic behaviour, such as hand washing or wearing a mask. This could give a
sense of the prevalence of these behaviours in the larger population, but care would need to be
taken to account for the fact that individuals knowing they will be surveyed could cause them to
engage in those behaviours more often and artificially inflate the observed rate of engagement
in prophylaxis.
5.2 Future Directions
Part of the goal in Chapter 2 was to develop an evolutionary explanation for the trend ob-
served across a wide variety of infectious diseases of increased immune investment in females
and increased pathogen disease-induced mortality in males. Previous literature, which ne-
glected host-pathogen coevolution, only addressed half of this trend. Authors have explained
sex differences in host immune investment as resulting from sexual selection acting on males
[24, 25, 26], sex differences in pathogen life history traits [29], and female reproduction (Chap-
ter 2 of this thesis). Other authors have provided explanations of the evolution of sex-specific
levels of pathogen disease-induced mortality as a result of inherent differences in host immune
investment [48] or vertical transmission [15]. While the coevolutionary model I have investi-
gated is able to provide a more complete explanation of the trend observed in clinical data, it
hinges on the possibility of vertical transmission. One open question that remains in this area,
then, is: How could hosts and pathogens have coevolved to a state of high female immune in-
vestment and high male disease-induced mortality, for diseases in which vertical transmission
does not occur? In their work on pathogen evolution in response to sex-specific differences in
hosts, Cousineau and Alizon [48] show how changing the structure of the transmission rate can
influence the level of virulence to which natural selection pushes the pathogen. In particular,
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they show how allowing a particular sex to infect only the same sex, only the opposite sex,
or a mixture of both sexes can select for different levels of virulence [48]. However, this is
only done in the case of pathogen evolution, so the coevolutionary consequences of this are not
clear. Investigating the role of contact patterns between the sexes on host-pathogen coevolution
could provide an alternate explanation for patterns of immune investment and disease-induced
mortality that does not rely on vertical transmission.
One of the assumptions made in Chapter 3 is that hosts have information on the entire
population when deciding whether or not to engage in prophylactic behaviour. In human popu-
lations, though, we know that hosts will make decisions based on their interactions with only a
subset of the population. Modelling such structure within the host population typically involves
using networks. In the case of epidemic models, previous authors have studied the effects of
different types of networks [94], sexually transmitted diseases spreading on networks of fe-
male and male hosts [95], and adaptive networks where individual hosts can change who they
are connected to over time [96]. Networks have been discussed as a way to model not only
infectious diseases but also the spread of information between individuals [78], or as a way
to explain pathogen adaptation from an inclusive-fitness perspective [97]. While this literature
links the ideas of spatial structure and infectious diseases, it is still unknown how this affects
predictions in scenarios where hosts are able to switch between different types. The model
presented in Chapter 3 of this thesis could be extended to study the consequences of a net-
work structure on predictions of the coevolution of host behaviour and pathogen exploitation.
For example, Wild, Gardner, and West [97] show that limited pathogen dispersal in a spatially
structured population can select for lower levels of virulence. However, in a spatially struc-
tured host population split into those engaging and not engaging in prophylactic behaviours,
pathogens with limited dispersal that find themselves in a group of hosts engaging in prophy-
laxis may no longer be at a selective advantage for lowering their virulence. Conversely, if
the pathogen reduces its virulence within a group of hosts, that creates less incentive for those
hosts to engage in prophylactic behaviours. If the fraction of hosts engaging in prophylaxis
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drops too low, the results presented in Chapter 3 suggest that natural selection will push for
increased pathogen virulence. Predicting the exact endpoint of host-pathogen coevolution in
such a setting requires further study of spatially structured coevolution models.
This idea of spatial structure can also be extended to scenarios like those discussed in
Chapter 4. Here, I have considered the effects of relatedness among pathogen strains on the
coevolution of hosts and pathogens, but I have not considered the effects of relatedness among
hosts. Hamilton’s [45] ideas on inclusive fitness pertain to hosts, as well, and so we would
expect to see closely related hosts cooperating with each other. In particular, if hosts are clus-
tered into groups and are closely related to those within their group, we would expect them
to invest more heavily in their immune systems in order to protect not only themselves but
also those around them. As seen in the sex-specific modelling of Cousineau and Alizon [48],
this increased immune investment could then select for higher pathogen virulence within that
host group. Understanding the interplay between host relatedness, pathogen relatedness, and
host-pathogen coevolution would involve extending the framework developed in Chapter 4 to
include spatially clustered and genetically related host groups.
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Appendix A
Chapter 2 - Evolutionary Analysis for
Simple Cases
This appendix provides more details on the evolutionary analysis conducted in the absence of
sex-specific differences, as discussed in the Results of the main text.
For the first case, where all sex differences are stripped away, we start our evolutionary
analysis by introducing a rare mutant-type pathogen with disease-induced mortality α̃. Trans-
mission from hosts infected with this mutant pathogen strain to susceptible hosts occurs at a
rate β̃, so the total number Ĩ of hosts infected by the mutant strain changes according to
dĨ
dt
= S̄ β̃Ĩ − (γ + α̃ + µ)Ĩ = [β̃S̄ − (γ + α̃ + µ)]Ĩ, (A.1)
where S̄ represents the equilibrium level of susceptible hosts in (2.15). From (A.1), we see that
the mutant pathogen population grows if β̃S̄ − (γ + α̃ + µ) > 0 and shrinks otherwise. This
allows us to define a fitness function for the mutant pathogen strain:
Wα(α̃, α) =
β̃S̄
γ + α̃ + µ
=
β̃(γ + α + µ)
β(γ + α̃ + µ)
. (A.2)
We can recognize β/(γ + α + µ) as the resident pathogen’s basic reproductive number, R0 [3]
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and so maximizing the mutant pathogen’s fitness equates to maximizing its basic reproductive
number, R̃0, as is a common theme in previous pathogen evolution literature (e.g., [10, 13]). If
we substitute in β = βmaxα̃/(α̃ + d), then R̃0 is maximized when
α̃ =
√
d(γ + µ). (A.4)
To study the evolution of hosts’ immune investment, we then introduce a rare mutant-type
host with recovery γ̂. If new mutant hosts are born at a rate b̂ = bmax − c(γ̂ + γ), then the total







(Ŝ + Î) + γ̂Î − Ŝ βI − µŜ (A.5a)
dÎ
dt
= Ŝ βĪ − (γ̂ + α + µ)Î, (A.5b)
where Ī represents the equilibrium level of infective resident hosts given in (2.15). The Jaco-




2 − βĪ − µ
b̂
2 + γ̂
βĪ −(γ̂ + α + µ)
 . (A.6)








 and V =
βĪ + µ −γ̂
−βĪ γ̂ + α + µ
 , (A.7)
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we can use a next-generation matrix approach [30] to define a fitness function Wγ for the
mutant-type host as the dominant eigenvalue of the matrix FV−1. Computing this eigenvalue
gives us the following fitness function:
Wγ(γ̂, γ) =
b̂[(b − 2µ)(γ − γ̂) + 2α(γ̂ + α + µ)]
2µ[b − 2(α + µ)](γ − γ̂) + 2bα(γ + α + µ)
. (A.8)
From this, we can find the selection gradient (∂Wγ/∂γ̂)|γ̂=γ and substitute in the expression
(A.4) for the evolutionarily stable level of pathogen disease-induced mortality.
We next consider the case where there are sex-specific levels of host recovery and pathogen
disease-induced mortality, but no inherent asymmetry between host sexes (i.e., no vertical
transmission, and female and male hosts incur the same reproductive cost to immune invest-
ment). As before, we start by introducing a rare mutant-type pathogen with disease-induced
mortality α̃ f in female hosts and α̃m in male hosts. If β̃i j represents the rate of transmission
from a sex- j host infected with the mutant strain to a susceptible sex-i host, then the number
of female hosts infected with the mutant strain, Ĩ f , and the number of male hosts infected with
the mutant strain, Ĩm, change according to
dĨ f
dt
= S f β̃ f f Ĩ f + S f β̃ f m Ĩm − (γ f + α̃ f + µ)Ĩ f (A.9a)
dĨm
dt
= S mβ̃m f Ĩ f + S mβ̃mm Ĩm − (γm + α̃m + µ)Ĩm. (A.9b)
We can then evaluate the Jacobian matrix of this subsystem at the mutant-free equilibrium (i.e.,
when Ĩ f = Ĩm = 0) to find
J =
S f β̃ f f − γ f − α̃ f − µ S f β̃ f mS mβ̃m f S mβ̃mm − γm − α̃m − µ
 . (A.10)
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Again using a next-generation matrix approach [30], we write (A.10) as J = F − V where
F =
S f β̃ f f S f β̃ f mS mβ̃m f S mβ̃mm
 and V =
γ f + α̃ f + µ 00 γm + α̃m + µ
 . (A.11)
A fitness function Wα for the mutant pathogen strain can then be defined as the dominant
eigenvalue of the matrix FV−1. To find the evolutionarily stable levels of disease-induced
mortality in female and male hosts, we look for roots of the selection gradients (∂Wα/∂α̃ f )|α̃ f =α f
and (∂Wα/∂α̃m)|α̃m=αm . While unwieldy to write out in their entirety, these selection gradients




α̃ f =α f
=









C(α2m − d(γm + µ))
D
, (A.13)
for positive constants A, B,C, and D. This allows us to find the evolutionarily stable lev-
els of pathogen disease-induced mortality to be α f =
√
d(γ f + µ) in female hosts and αm =√
d(γm + µ) in male hosts, which are of a similar form to the evolutionarily stable level of
pathogen disease-induced mortality (A.4) found in the absence of any sex differences.
Next, we introduce a rare mutant-type host with recovery levels γ̂ f in females and γ̂m in
males. As discussed in the main text, new mutant hosts are born when a host heterozygous
for the mutation mates with a resident (homozygous) host. System (2.11) describes how the
numbers of susceptible and infective mutant female hosts, Ŝ f and Î f , change over time. Under
the simplifying assumptions made here of no vertical transmission and no sex-specific repro-
ductive costs to immune investment, this system reduces to





2 (Ŝ f + Î f )(S m + Im) +
b̂m
2 (S f + I f )(Ŝ m + Îm)
N




= Ŝ fβ f f I f + Ŝ fβ f mIm − (γ̂ f + α f + µ)Î f , (A.14b)
where b̂ f = bmax−c(γ̂ f +γm) and b̂m = bmax−c(γ f + γ̂m). An analogous set of equations governs
the dynamics of the numbers of susceptible and infective mutant male hosts, Ŝ m and Îm. The
Jacobian matrix of this four-dimensional subsystem, evaluated at the mutant-free equilibrium

























2 (S f +I f )
N
0 0 0 0






β f f I f + β f mIm + µ 0 −γ̂ f 0
0 βm f I f + βmmIm + µ 0 −γ̂m
−β f f I f − β f mIm 0 γ̂ f + α f + µ 0
0 −βm f I f − βmmIm 0 γ̂m + αm + µ

. (A.16)
The dominant eigenvalue of the matrix FV−1 can then be used as a fitness function Wγ for the
mutant host [30]. While this fitness function can be computed analytically, finding the roots
of the associated selection gradients to compute the evolutionarily stable level of host immune
investment must be done numerically.
Appendix B
Chapter 3 - Details of the Replicator
Dynamics
Here, we present the details of the derivation of equations (3.3) and (3.4). The replicator
dynamic tells us that an individual’s decision to start or stop engaging in prophylaxis is propor-
tional to the utility difference between the focal susceptible (resp. infective) individual and the
average susceptible (resp. infective) individual in the population, taking into account the utility
cost that the focal individual must pay to engage in the prophylactic behaviour. Specifically, the
replicator dynamic equation allows us to replace the τi j terms in our model with the following:
− τ01x + τ10(1 − x) = kx((Ufoc − χ) − Uavg), (B.1)
where Ufoc represents the utility of the focal susceptible individual, Uavg represents the utility
of the average susceptible individual in the population, and k is a constant that reflects the rate
at which individuals change their behaviour based on the behaviour of others. As described
in the main text, we measure utility by the force of infection so that the benefit gained by
an individual choosing to engage in prophylaxis is a reduced force of infection relative to the
average individual. The utility of a focal susceptible individual engaging in prophylaxis, then,
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is given by
Ufoc = −(β10(1 − y) + β11y)v, (B.2)
while the utility of the average susceptible individual in the population is given by
Uavg = −[x(β10(1 − y) + β11y) + (1 − x)(β00(1 − y) + β01y)]v. (B.3)
Substituting these into the replicator dynamic equation gives
− τ01x + τ10(1 − x) = kx(1 − x)[y(β01 − β11) + (1 − y)(β00 − β10)]v − kχx, (B.4)
which is equation (3.3) in the main text.
We can derive equation (3.4) in a similar way. Since there is no force of infection acting on
an infective individual, the utility of both a focal infective individual engaging in prophylaxis
and an average infective individual in the population is zero. However, an infective individual
who decides to engage in prophylaxis must still pay the cost of that behaviour. In this case,
then, the replicator dynamic equation gives
− φ01y + φ10(1 − y) = −kχy. (B.5)
Appendix C
Chapter 3 - Linear Stability Analysis
The full resident system of our model (3.5) in the main text is built on the standard two-
dimensional SIR model. This standard two-dimensional model has a Jacobian matrix of
J =
−β00v − 1 −β00uβ00v β00u − 1 − γ
 . (C.1)
which, when evaluated at the disease-free equilibrium (DFE) (ū, v̄) = (1, 0), has eigenvalues
λ1 = −1 and λ2 = β00 − 1 − γ. The DFE is stable when both eigenvalues are negative, which
leads us to the condition that R0 = β00/(1 + γ) < 1 for stability.
WhenR0 exceeds this threshold, the DFE becomes unstable and the standard two-dimensional
system moves towards an endemic equilibrium (ū, v̄) = (1/R0, (1−1/R0)/(1+γ)). To determine
the region in which this equilibrium remains stable after we incorporate the host behavioural
dynamics, we need to consider the Jacobian matrix of our four-dimensional system (3.5) eval-
uated at (ū, v̄, x̄, ȳ) = (1/R0, (1 − 1/R0)/(1 + γ), 0, 0):

−β00v̄ − 1 −1 − γ ∗ ∗
β00v̄ 0 ∗ ∗
0 0 k(χc − χ) 0
0 0 β10(1+γ)
β00
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(R0 − 1) + 1
)
and asterisks denote entries that are possibly non-zero.
Since this matrix is block upper triangular, the eigenvalues are given by the eigenvalues of
the 2 × 2 matrices on the diagonal. The 2 × 2 matrix in the upper left is the Jacobian matrix
of the standard two-dimensional SIR model evaluated at the endemic equilibrium (ū, v̄, x̄, ȳ),
which we know has negative eigenvalues whenever R0 > 1. The 2 × 2 matrix in the bottom
right is lower triangular, so its eigenvalues are the entries on the main diagonal. The second
of these entries is always negative, while the first is negative as long as χ > χc. This defines a
critical cost threshold where for χ > χc the endemic equilibrium (ū, v̄, x̄, ȳ) is stable, while for
χ < χc our system tends towards an endemic equilibrium that contains individuals engaging in
prophylaxis in some non-zero quantities.
Appendix D
Chapter 3 - Evolutionary Analysis of
Simple Cases
Two simple cases, where evolutionary analysis is possible analytically, were discussed in Chap-
ter 3 of the main text. Here, we outline the details of that analysis.
The first special case is when the cost of prophylaxis exceeds the threshold χc. In this
case, our linear stability analysis shows that the stable endemic equilibrium is (ū, v̄, x̄, ȳ) =
(1/R0, (1 − 1/R0)/(1 + γ), 0, 0), where R0 = β00/(1 + γ). We can then solve equation (3.8b) to
find two possible equilibria for ym: ȳm = 0 or ȳm = 1/ε + (kχ/(ε(1 + ξm)). Since ε ≤ 1, the
second of these values is always larger than one and so is not biologically sensible, as ym is
defined to be a proportion. Checking the sign of d/dym(dym/dt) at the first of these equilibrium
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This results in a CSS value of ξ̄ =
√
κ.
The second special case is when the prophylactic measures are cost-free, i.e., χ = 0. As
noted in the main text, the system moves towards an endemic equilibrium where some non-
zero proportions of susceptible and infective individuals are engaging in prophylaxis. While
we do not have exact analytic expressions for these equilibrium values, we can still solve for
ȳm analytically. Under the assumption of zero cost, solving equation (3.8b) gives two possible
equilibrium values for ym: ȳm = 1/ε and ȳm = (εx̄− x̄)/(εx̄− 1). Since ε ≤ 1 and x̄ ≤ 1, the first
of these is always larger than one and the second is always on the interval [0, 1]. Substituting
the second of these values into (d/dym)(dym/dt) shows that ȳm = (εx̄ − x̄)/(εx̄ − 1) is the stable
equilibrium. Notably, this equilibrium value is independent of the mutant exploitation ξm and
so the fitness function has the form
W(ξm, ξ) =
ξm
(κ + ξm)(1 + γ(ξm))
B(ξ)ū(ξ), (D.3)
where B(ξ) represents what remains from βavg(ξm, ξ) after factoring out the terms involving ξm.







(κ + ξ̄)2(1 + ξ̄)2
B(ξ̄)ū(ξ̄) = 0. (D.4)




Chapter 3 - Evolutionary Analysis in the
Case of Arbitrary Cost
While a full evolutionary analysis of the model in the case of an arbitrary cost value is possible
only numerically, we expand here on some analytical details of this case discussed in the main
text. In particular, we show that there is a unique stable equilibrium value of ym on the interval
[0, 1], and that the derivative dȳm/dξm evaluated at ξm = ξ is always positive and discuss the
implications of this on the fitness function.
In order to numerically perform the evolutionary invasion analysis, we first need to know
that there is a unique equilibrium value of ym on the interval of [0, 1] and that this value is stable.
To find the equilibrium values of ym, we need to solve equation (3.8b). The right-hand side of
this equation is a quadratic polynomial in ym, so we know there are two possible equilibrium




βmax(1 − ε)ξm x̄ū
κ + ξm
, (E.1)
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which is negative since ε ∈ [0, 1] and x̄ ∈ [0, 1]. By the Intermediate Value Theorem and the
fact that the right-hand side of (3.8b) is quadratic in ym, this then shows that there is a unique
equilibrium value of ym in the interval [0, 1]. Moreover, since the derivative dym/dt is positive
at ym = 0 and negative at ym = 1, this equilibrium value is stable.
With this knowledge, we are able to solve (3.8b) and get an explicit expression for the
equilibrium value ȳm. To understand how this value interacts with the fitness function (3.9),
we need to understand how ȳm changes with ξm. Differentiating with respect to ξm, we are able
to get an explicit expression for dȳm/dξm and evaluate when ξm = ξ. Doing so results in an











where a = kχ(κ + ξ) + βmax(1 − ε2 x̄)ū, b = 4β2maxε(1 − ε)(1 − εx̄)ξ
2ū2 x̄, and c = 2βmaxε(1 −
εx̄)ξ2ū
√
a2 − b/kχκ. The fact that ε ∈ [0, 1] and x̄ ∈ [0, 1] allows us to conclude that a, b,
and c are all positive. Some simplification of the radicand also shows that a2 − b ≥ 0, so
we are guaranteed that equation (E.3) is real-valued. This proves that
√
a2 − b ≤ a and, thus,
(dȳm/dξm)|ξm=ξ ≥ 0.
To see how this affects the evolution of pathogen exploitation, we need to pull apart the
fitness function in equation (3.9). Finding a potential CSS value of ξ involves first solving











where primes denote derivatives with respect to ξm evaluated when ξm = ξ = ξ̄. This further










In the absence of individuals engaging in prophylaxis, βavg = β00 and so solving for the CSS
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value ξ̄ amounts to balancing the standard trade-off between transmission and recovery. How-
ever, when individuals take prophylactic measures, βavg becomes more complicated. To under-
stand how βavg responds to changes in exploitation in this case, we take a closer look at β′avg.
Using the definition of βavg given in the main text, we have that
β′avg =
[













︸                 ︷︷                 ︸
I
− ȳ′m
β00 − β01β10 − β11




It follows from the fact that β00 ≥ β01 = β10 ≥ β11 and the above proof that ȳ′m ≥ 0 that
terms I and II in equation (E.6) are non-negative. Accounting for individuals engaging in
prophylaxis—in particular, infective individuals engaging in prophylaxis—reduces β′avg below
the level we would expect in the absence of those measures. If the pathogen increases its
exploitation, it leads to an increase in the proportion of infective individuals engaging in pro-
phylactic measures due to the fact that ȳ′m ≥ 0. This increases the likelihood that the rate of
transmission between a susceptible individual and an infective individual will be one of β01 or
β11, instead of β00 or β10. Since β01 and β11 are always smaller than β00 and β10, this leads to a
reduction in the rate of change of the average transmission rate in the population. This influ-
ence on the rate of change of transmission intertwines with the more standard trade-off between
transmission and recovery, and reduces the evolutionarily stable level of pathogen exploitation
below what we would expect in the absence of prophylaxis.
Appendix F
Chapter 3 - Perturbation Analysis
Letting r = (u, v, x, y) and s = ξ, we can express the four equations governing the epi-
demiological dynamics of our system as the vector-valued function F(r, s; χ) and the equa-
tion describing the evolutionary dynamics of pathogen exploitation as the scalar-valued func-
tion G(r, s; χ). We know that below the critical cost threshold χc the endemic equilibrium
(r̂, ŝ) = (û, v̂, x̂, ŷ, ξ̂) is stable, while above this threshold our system tends towards the endemic
equilibrium (r̄, s̄) = (ū, v̄, 0, 0, ξ̄) where individuals engaging in prophylaxis are absent. The
critical cost level represents a bifurcation point where these two equilibria coincide and un-
dergo an exchange of stability. To study how our system reacts as we decrease the cost away
from this threshold, we introduce a perturbation parameter δ = χ − χc and take a first-order
approximation to our new equilibrium point (r̂, ŝ) = (ū + ρ1δ, v̄ + ρ2δ, ρ3δ, ρ4δ, ξ̄ + σδ). Know-
ing that this equilibrium point must satisfy F(r̂, ŝ; χ) = 0 and G(r̂, ŝ; χ) = 0, our goal is to find
expressions for the perturbation coefficients ρ1, ρ2, ρ3, ρ4, and σ.
If we treat (r̂, ŝ) as a function of χ, we can make a first-order Taylor series approximation
centred around χc:
F(r̄, s̄; χc) + δ[Dr̂F(r̄, s̄; χc)dr̂ + Fŝ(r̄, s̄; χc)dŝ + Fχ(r̄, s̄; χc)] = 0 (F.1a)
G(r̄, s̄; χc) + δ[Gr̂(r̄, s̄; χc)dr̂ + G ŝ(r̄, s̄; χc)dŝ + Gχ(r̄, s̄; χc)] = 0, (F.1b)
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where subscripts denote partial derivatives and dr̂ = (ρ1, ρ2, ρ3, ρ4) and dŝ = σ are the deriva-
tives with respect to χ of r̂ and ŝ, respectively. We know that (r̄, s̄) is an equilibrium point, so
the first term in equations (F.1a) and (F.1b) evaluates to zero. We also observe that every term
in F and G involving χ is multiplied by at least one of x or y, and so the partial derivatives with
respect to χ vanish when we evaluate at (r̄, s̄). This simplifies (F.1) to:
Dr̂F(r̄, s̄; χc)dr̂ + Fŝ(r̄, s̄; χc)dŝ = 0 (F.2a)
Gr̂(r̄, s̄; χc)dr̂ + G ŝ(r̄, s̄; χc)dŝ = 0. (F.2b)
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with asterisks denoting entries that are possibly non-zero. Since J is a block triangular matrix,
the eigenvalues are given by the eigenvalues of the matrices on the main diagonal. The 2 × 2
matrix in the upper left is the Jacobian matrix arising from the linearization of the standard
SIR model around the endemic equilibrium (r̄, s̄). Since the lower-right 3 × 3 block is lower
triangular and has a zero entry on its main diagonal, we can see that zero is an eigenvalue of J.




as the eigenvector of J associated with the zero eigenvalue, and
so shows that there is a non-trivial solution for our perturbation coefficients.
While an analytic expression for this eigenvector can be found, it is unwieldy. Of more
interest is the sign of the perturbation coefficient σ, as this tells us in which direction ξ̄ moves
as we decrease the cost below its critical value. The third row of (F.3) tells us that x̄ is a free
variable, and the last row tells us that there is a simple relationship between this free variable
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We know that the denominator of (F.4) is always negative since ξ̄ =
√
κ is convergence stable
(see (3.11)). Furthermore, the proportion of susceptible individuals engaging in prophylaxis
increases as the cost is decreased below its critical value and δ = χ − χc < 0 below this cost
threshold, so we must have that ρ3 < 0. It follows, then, that the sign of σ is controlled only by
the numerator of (F.4) and so we arrive at equation (3.14) in the main text.
Appendix G
Chapter 3 - Maple Code
Here, we present the Maple code, described in Chapter 3 of the main text, used to check the sign
of the perturbation coefficient σ for a range of parameter values near the critical cost threshold.
Using δ = χ − χc as our perturbation parameter, we first define the differential equation for ym
in (3.8b) and solve for the equilibrium value:
restart:
with(LinearAlgebra): with(VectorCalculus): with(plots):
dymdt := -(y[m]*(beta[max]*(1 - epsilon)*xi[m]*(1 - x)*
y[m]/(kappa + xi[m]) - beta[max]*(1 - epsilon)ˆ2*xi[m]*
x*(1 - y[m])/(kappa + xi[m])) + (1 - y[m])*(beta[max]*
xi[m]*(1 - x)*y[m]/(kappa + xi[m]) - beta[max]*
(1 - epsilon)*xi[m]*x*(1 - y[m])/(kappa + xi[m])))*u
- k*(chi[c] + delta)*y[m]:
Solving this equation returns two possible equilibrium values:
ym := solve(dymdt, y[m]):
simplify(subs(delta = chi - chi[c], ym[1])):
simplify(subs(delta = chi - chi[c], ym[2])):
These equilibrium values are of the form (a ±
√
b)/c. Knowing that 0 ≤ ε ≤ 1 and 0 ≤ x̄ ≤ 1
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allows us to conclude that a ≤ 0, b ≥ 0, and c ≤ 0. Furthermore, some algebra shows that
b ≤ a2 and so
√
b ≤ |a|. This allows us to conclude that 0 ≤ ym[1] ≤ ym[2]. We now check
the derivative of the differential equation to find the stable equilibrium:
simplify(subs(y[m] = ym[1], diff(dymdt, y[m]))):
simplify(subs(y[m] = ym[2], diff(dymdt, y[m]))):
Since the first of these quantities is negative and the second is positive, this shows that the first
root ym[1] is the stable equilibrium. The proof in Appendix E shows that there is a unique
stable equilibrium on the interval [0, 1], and so we are guaranteed that ym[1] is on [0, 1]. Thus,
we define this as the equilibrium value of ym:
ym := ym[1]:
We now define the differential equations for u, v, x, and y in (3.5), as well as the partial deriva-
tive of the fitness function with respect to the mutant pathogen exploitation level ξm:
dudt := 1 - (beta[max]*xi*(1 - x)*(1 - y)/(kappa + xi)
+ beta[max]*(1 - epsilon)*xi*(1 - x)*y/(kappa + xi)
+ beta[max]*(1 - epsilon)*xi*x*(1 - y)/(kappa + xi)
+ beta[max]*(1 - epsilon)ˆ2*xi*x*y/(kappa + xi))*u*v - u:
dvdt := (beta[max]*xi*(1 - x)*(1 - y)/(kappa + xi)
+ beta[max]*(1 - epsilon)*xi*(1 - x)*y/(kappa + xi)
+ beta[max]*(1 - epsilon)*xi*x*(1 - y)/(kappa + xi)
+ beta[max]*(1 - epsilon)ˆ2*xi*x*y/(kappa + xi))*u*v - (1 + xi)*v:
dxdt := -x/u + (k + 1)*x*(1 - x)*(y*(beta[max]*(1 - epsilon)*
xi/(kappa + xi) - beta[max]*(1 - epsilon)ˆ2*xi/(kappa + xi))
+ (1 - y)*(beta[max]*xi/(kappa + xi) - beta[max]*(1 - epsilon)*
xi/(kappa + xi)))*v - k*(chi[c] + delta)*x:
dydt := -(beta[max]*xi*(1 - x)*y*(1 - y)/(kappa + xi)
+ beta[max]*(1 - epsilon)*xi*(1 - x)*yˆ2/(kappa + xi)
- beta[max]*(1 - epsilon)*xi*x*(1 - y)ˆ2/(kappa + xi)
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- beta[max]*(1 - epsilon)ˆ2*xi*x*y*(1 - y)/(kappa + xi))*u
- k*(chi[c] + delta)*y:
W := (beta[max]*xi[m]*(1 - x)*(1 - ym)/(kappa + xi[m]) + beta[max]*
(1 - epsilon)*xi[m]*(1 - x)*ym/(kappa + xi[m]) + beta[max]*
(1 - epsilon)*xi[m]*x*(1 - ym)/(kappa + xi[m]) + beta[max]*
(1 - epsilon)ˆ2*xi[m]*x*ym/(kappa + xi[m]))*u/(1 + xi[m]):
dWdxi := subs(xi[m] = xi, diff(W, xi[m])):
Using this, we put together the matrix J described in Appendix F:
J1 := Jacobian([dudt, dvdt, dxdt, dydt], [u, v, x, y] =
[(1 + sqrt(kappa))*(kappa + sqrt(kappa))/(beta[max]*sqrt(kappa)),
(1 - (1 + sqrt(kappa))*(kappa + sqrt(kappa))/(beta[max]*
sqrt(kappa)))/(1 + sqrt(kappa)), 0, 0]):
J2 := <0, 0, subs(u = (1 + sqrt(kappa))*
(kappa + sqrt(kappa))/(beta[max]*sqrt(kappa)),
x = 0, delta = 0, diff(dWdxi, x)), 0>ˆ%T:
J3 := subs(u = (1 + sqrt(kappa))*(kappa + sqrt(kappa))/
(beta[max]*sqrt(kappa)), v = (1 - (1 + sqrt(kappa))*(kappa
+ sqrt(kappa))/(beta[max]*sqrt(kappa)))/(1 + sqrt(kappa)),
x = 0, y = 0, delta = 0, Jacobian([dudt, dvdt, dxdt, dydt, dWdxi],
[xi] = [sqrt(kappa)])):
J4 := <J1, J2>:
J5 := <J4 | J3>:
J := subs(chi[c] = beta[max]*sqrt(kappa)/((1 + sqrt(kappa))*(kappa
+ sqrt(kappa))) - (k + 1)*((1 - epsilon)*(beta[max]*sqrt(kappa)/((1
+ sqrt(kappa))*(kappa + sqrt(kappa))) - 1) + 1)/k, xi = sqrt(kappa),
delta = 0, J5):
We then extract the entry of J corresponding to the partial derivative in (3.14). We also define
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the critical cost threshold χc in (3.6):
sigmanum := simplify(J[5, 3]):
costthresh := beta[max]*sqrt(kappa)/((1 + sqrt(kappa))*(kappa
+ sqrt(kappa))) - (k + 1)*((1 - epsilon)*(beta[max]*
sqrt(kappa)/((1 + sqrt(kappa))*(kappa + sqrt(kappa))) - 1) + 1)/k:
If we choose βmax and κ values so that R0 > 1, we get the following curve (where above the
curve R0 > 1 and below the curve R0 < 1):
R0plot := plot((1 + sqrt(kappa))ˆ2, kappa = 0 .. 5,
color = BLACK, thickness = 3, view = [0 .. 5, 0 .. 10],
labels = [kappa, beta[max]]):
If we also choose ε values so that χc > 0 and k values so that ε < 1, we can generate a series
of βmax-κ curves and plot them together with the previous curve for R0:
expressions := [seq(seq(subs([epsilon = beta[max]/(((1
+ sqrt(kappa))ˆ2/(beta[max] - (1 + sqrt(kappa))ˆ2) + 10ˆn
+ 1)*(beta[max] - (1 + sqrt(kappa))ˆ2)) + m*(((1
+ sqrt(kappa))ˆ2/(beta[max] - (1 + sqrt(kappa))ˆ2) + 10ˆn)
- (1 + sqrt(kappa))ˆ2/(beta[max] - (1 + sqrt(kappa))ˆ2))/
(10*((1 + sqrt(kappa))ˆ2/(beta[max] - (1 + sqrt(kappa))ˆ2)
+ 10ˆn + 1)), k = (1 + sqrt(kappa))ˆ2/(beta[max]
- (1 + sqrt(kappa))ˆ2) + 10ˆn], costthresh), m = 1 .. 9),
n = -2 .. 2)]:
for i to 45 do
p[i] := plot({solve(expressions[i], beta[max])},
kappa = 0 .. 5, color = GREY, linestyle = DASH):
end do:
display({R0plot, seq(p[i], i = 1 .. 45)},
view = [0 .. 5, 0 .. 10], labels = [kappa, beta[max]]):
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This generates the plot in panel A of figure 3.2 and suggests that all of the χc = 0 curves
overlap with the R0 = 1 curve, meaning that the region in which R0 > 1 coincides with the
region in which χc > 0. We can confirm this by looking at the difference between these two
curves; running the following line of code will show that this difference is always exactly zero:
for i to 45 do
simplify((1 + sqrt(kappa))ˆ2 - solve(expressions[i],
beta[max])[2]):
end do:
If we use the ε and k values chosen above, we can also look at the value of the partial derivative
in equation (3.14). This gives a second set of βmax-κ expressions that we can plot over top of
the expressions for χc and R0 above:
expressions2 := [seq(seq(subs([epsilon = beta[max]/(((1
+ sqrt(kappa))ˆ2/(beta[max] - (1 + sqrt(kappa))ˆ2) + 10ˆn
+ 1)*(beta[max] - (1 + sqrt(kappa))ˆ2)) + m*(((1
+ sqrt(kappa))ˆ2/(beta[max] - (1 + sqrt(kappa))ˆ2) + 10ˆn)
- (1 + sqrt(kappa))ˆ2/(beta[max] - (1 + sqrt(kappa))ˆ2))/(10*
((1 + sqrt(kappa))ˆ2/(beta[max] - (1 + sqrt(kappa))ˆ2)
+ 10ˆn + 1)), k = (1 + sqrt(kappa))ˆ2/(beta[max] - (1
+ sqrt(kappa))ˆ2) + 10ˆn], sigmanum), m = 1 .. 9),
n = -2 .. 2)]:
for i to 45 do
p2[i] := plot({solve(expressions2[i], beta[max])},
kappa = 0 .. 5, color = GREY, linestyle = DOT):
end do:
display({R0plot, seq(p[i], i = 1 .. 45), seq(p2[i], i = 1 .. 45)},
view = [0 .. 5, 0 .. 10], labels = [kappa, beta[max]]):
This produces the plot shown in panel B of figure 3.2 and shows that all of these curves that
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represent the roots of the partial derivative in (3.14) lay below the curve for R0 = 1. So for
all sensible sets of parameter values (i.e., all parameter values that satisfy χc > 0 and R0 > 1),
(3.14) has the same sign. We can take a test point in this region of parameter space to show
that this sign is always positive, meaning that in a neighbourhood below the critical cost value
the CSS pathogen exploitation level will decrease below its benchmark value.
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